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Abstract 
 
 Self-healing technology offers an autonomic route to repairing damage in advanced 
polymers to extend their lifetime.  A variety of self-healing systems have been developed for 
mechanical self-healing, protective coatings, and electronic self-healing.  These self-healing 
systems rely on functional groups within the polymer, microvascular networks, or 
compartmentalization in capsules and particles.  The healing agents become active in the crack 
plane upon damage, forming new bonds that heal the material.  Of these systems, 
compartmentalization offers a simple and inexpensive means to apply self-healing to current 
advanced polymer applications.   
 In this research, the primary motivation is to address challenges associated with small 
size-scale self-healing in compartmentalized systems.  The term “small size-scale” in self-healing 
technology is applied to technologies where components are between 100 and 2000 nm.  As the 
size of the capsules and particles decreases, current encapsulation methods do not ensure that 
self-healing components disperse well in a polymer matrix and that the components retain their 
contents during processing.  The ring-opening metathesis polymerization reaction between 
dicyclopentadiene and Grubb’s catalyst is especially important to self-healing applications and 
provides a model system that uses both encapsulated liquid and solid healing agents.  DCPD is 
encapsulated in polyureaformaldehyde (PUF) capsules while catalyst is protected in wax 
particles.   
 Silica coatings, applied using a variety of silica condensation chemistries, help to 
improve the functionality of liquid-filled capsules.  Fluoride-catalyzed silica condensation offers 
the best route to coating PUF capsules with a variety of sizes and contents.  Coated capsules, 1.5 
m in diameter, can be dried to a powder without aggregates, something that cannot be achieved 
without the coating.  Although a silica shell adds an additional diffusion barrier to the capsules, 
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the stability of PUF capsules relies more on the washing conditions and capsule contents than on 
the addition of a silica shell.   
 Polymer protection of Grubbs’ catalyst allows the catalyst to be incorporated into an 
epoxy matrix at smaller size scales without deactivation.  The final particles contain catalyst 
encapsulated in particles made of polystyrene (PS) and polymethylmethacrylate (PMMA) and 
coated with silica.   At larger size-scales, the polystyrene is sufficient to protect the particles and 
helps to improve the thermal stability of the particles compared to as-received Grubbs’ catalyst or 
catalyst encapsulated with wax.   
One important application requiring small size-scale self-healing components is in fiber-
rich regions of epoxy composites where the spacing between fibers is limits the size of the 
components that can be used for self-healing.  The small size scale self-healing components, 
DCPD capsules and Grubbs’ catalyst particles, are successfully incorporated into epoxy without 
aggregation or deactivation and demonstrate nominal healing.  The size of the capsules limits the 
amount of healing agent delivered to the crack plane so pressure is applied across the crack plane, 
decreasing the crack volume and improving healing.  PS in the catalyst particles also contributes 
to healing as it is dissolved by the DCPD and redeposits in the crack plane.  The full system 
provides a healing efficiency of approximately 25%.   
Another important application requiring small size-scale self-healing components is in 
optical self-healing.  10 m thick PMMA coatings containing 1.5 m in diameter dibutyl 
phthalate (DBP) capsules scatter minimal light as a result of index matching.  The capsules are 
capable of partially healing sub-micron damage in 100 m PMMA films that have been 
mechanically damaged.  The healed material scatters minimal light and retains the protective 
capabilities of the original PMMA coating.  Larger capsules, 80 m in diameter, containing DBP 
provide more healing allowing full healing at 6 wt.% capsules in polymer.  They scatter more 
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light than the 10 m coatings containing 1.5 m in diameter capsules but are still more optically 
clear than systems with poor index matching.   
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CHAPTER 1 
INTRODUCTION 
 
1.1 Autonomic Self-healing Polymers 
Self-healing technology offers an important mechanism for extending the lifetime of 
advanced polymers in many applications.  Similar to the biology of a cut where proteins, platelets 
and other components from the blood are recruited to the damaged skin, healing agents are 
incorporated into a polymer, and are recruited to damage in polymers, polymerizing to form new 
material in the damaged region.  White et al. demonstrated a self-healing system where healing 
agents are incorporated into polymer as capsules or particles (Figure 1.1).[1]  As a crack 
propagates through the polymer matrix, the healing agents release into the crack plane, mix, and 
form new polymer.   Newer self-healing technologies rely on an expanded set of solutions for 
incorporating healing agents into a polymer.[2]  The original self-healing system where self-
healing agents are phase separated in a polymer matrix is considered a compartmentalized self-
healing system.[3-19]  A microvascular system incorporates the healing agents into the polymer 
matrix through microchannels similar to blood vessels in biology.[20-24]  Finally, molecular 
systems incorporate reactive agents into the backbone of the polymer.[25-33]   
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Figure 1.1. Schematic of the self-healing process.  Catalyst and microcapsules are incorporated 
into a polymer matrix (a).  As a crack propagates through the polymer, healing agent is released 
into the crack plane (b).  When the healing agent meets catalyst in the polymer, it polymerizes 
creating new polymer (c).  Figure adapted from [1]. 
 
1.1.1 Microvascular Self-healing Systems 
 Microcascular self-healing systems incorporate healing agents into a polymer matrix 
through microchannels similar to blood vessels in biology (Figure 1.2).  The primary advantage 
to these systems is that multiple healing events can occur as long as the vascular networks can be 
refreshed.  The original concept proposed by Toohey et al. was made of a microchannel network 
containing dicyclopentadiene (DCPD).  The microchannels delivered DCPD to an epoxy surface 
coating containing Grubbs’ catalyst.[20]  One of the advantages to this system is the variety of 
healing that can be used.  Molecular self-healing systems are limited by synthetic routes to 
modifying a polymer while compartmentalized systems are limited by solution encapsulation 
methods that require good phase separation.  As a result, more recent work demonstrated healing 
(a)
(b)
(c)
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using a 2 microchannel system where one set of channels contained epoxy resin and the other 
contained epoxy hardener.[21, 22]  These systems are limited to healing a coating only but other 
microvascular systems use microchannels that can heal in bulk epoxy.  Trask et al.[23] use 
hollow microfibers to deliver healing agents throughout a composite material while Hamilton et 
al. [24] fabricated 3-D microvascular networks in epoxy using a robocasting method. 
 
 
Figure 1.2. (a) microvascular network where healing agents are delivered to an epoxy coating, 
and (b) a microvascular network where healing agents are delivered throughout the polymer 
matrix.  Adapted from reference [24]. 
 
1.1.2 Molecular Self-healing Systems 
 Molecular self-healing systems incorporate mechanically responsive moieties into the 
backbone of the polymer.  In many cases, these moieties are reversible bonds that rely on 
hydrogen bonding or high temperature for construction and deconstruction.[25-27]   This is a 
promising route because multiple healing events can be achieved due to the reversibility.  More 
recently, mechanochemistry has demonstrated promise where mechanical force in the polymer 
matrix opens new functionalities within the polymer backbone. Hickenboth et al. demonstrated 
such a phenomenon using benzocyclobutanes [28, 29] while Potisek et al. later demonstrated 
chemical reactions that could take place using the benzocyclobutane group.[29]  Since then other 
(a) (b)
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mechanoresponsive moieties have been used for color changing,[30, 31] unveiling of 
cyanoacrylates,[32] and opening of gem-dichlorocyclopropanes.[33]  One of the challenges with 
molecular self-healing systems is the low quantity of mechanically responsive moieties present in 
a damaged region.   
 
1.1.3 Compartmentalized Self-healing Systems 
 Compartmentalized self-healing systems require encapsulation of healing agents and 
these encapsulated healing agents are incorporated into a polymer matrix.  Due to its simplicity, 
low cost and the relatively high volume of healing agent delivered, much work has been done 
towards implementing the system in a variety of applications using a variety of chemistries.  
These systems and chemistries can be divided into the properties they are capable of healing.   
 
1.1.3.1 Mechanical Self-healing 
Mechanical properties, including fracture toughness and fatigue, require good bonding 
between the healed polymer and the crack surface.  The self-healing chemistry chosen by White 
et al. is based on the ring opening methathesis polymerization of Dicyclopentadiene (DCPD) in 
the presence of Grubbs’ catalyst (Figure 1.3). These components are incorporated into an epoxy 
matrix based on diglycidal ether of bisphenol A (DGEBA) and diethylene triamene (DETA).  The 
resulting healed region maintains its mechanical integrity through mechanical and Van der Waals 
bonding.  The recovery of a material’s mechanical properties using the DCPD/Grubbs’ catalyst 
system is particularly applicable to composites where subsurface damage occurs that is difficult 
to detect and fix manually.[3-6]  The chemistry has also been used in the development of self-
healing adhesives.[7]   
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Figure 1.3 Schematic of the reaction between Grubbs’ catalyst and DCPD. 
 
A variety of self-healing chemistries have been developed more recently to improve the 
interaction between the healed material and an epoxy matrix.  These include epoxy,[8, 9] 
isocyanate,[10] and solvent welding [11] chemistries.  In addition, other chemistries have been 
developed that work with other matrices.  Siloxane chemistries, for example have been used in 
vinyl ester matrices [12] and PDMS.[13]  
 
1.1.3.2 Protective Coatings 
Protective coatings require that the healing chemistry provide a barrier between the 
coating’s substrate and the outside environment.  The barrier does not need to fill the crack plane 
and does not need an excellent mechanical bond with the coating.  Initial work in this area 
encapsulated film forming liquids, such as castor oil, into a polymer coating.[14]  As the liquid 
released into the crack plane, it coated the substrate and provided the barrier between the 
substrate and the surrounding environment.  By including corrosion inhibitors, the efficacy of the 
film was enhanced.  More recently, polymerization reactions involving siloxane chemistry have 
been used to improve the mechanical properties of the films released (Figure 1.4).[15, 16] 
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Figure 1.4. An epoxy vinyl ester matrix (a) without and (b) with an encapsulated self-healing 
siloxane chemistry.   
 
1.1.3.3 Electronic Self-healing 
A more recent type of self-healing involves release of conductive healing agents that can 
bridge gaps in a circuit and regain the electrical properties of the undamaged circuit.  Initial work 
by Caruso et. al. demonstrated encapsulation of carbon nanotubes (CNT) in 
polyureaformaldehyde capsules and demonstrated release of the CNTs upon capsule rupture.[17]  
Odom et. al. demonstrated the use of charge transfer salts as a conductive healing agents.[18]  
More recent work has demonstrated device architecture where low melting point eutectics were 
released into an active circuit.[19]  Instead of releasing conductive components, Odom et. al. also 
developed a device where solvents dissolved and redeposited electronic circuits made of 
conductive paint.[19]   
 
1.2 Challenges for Compartmentalized Self-healing 
1.2.1 Small Size-scale Self-healing 
 Small size-scale self-healing systems are important in applications where space is limited.  
In composites, interstitial spaces between fibers, where the volume is micron size or smaller, 
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requires encapsulated healing agents with sub-micron diameter.[34, 35]  Blaiszik et al. 
demonstrated successful healing of interfacial damage between fibers and epoxy using micron 
size capsules.[34]  For optical polymers, self-healing components on the order of 1 μm in 
diameter provide several advantages.  First, many optical polymers are used as coatings where the 
thickness of the coating limits the size of the capsules.  The use of thinner coatings also limits 
scattering from the capsules and is therefore important for obtaining optically clear polymers 
containing capsules.  Finally, many optical polymers are thermoplastic and are subject to crazing 
damage [36, 37] which may not effectively rupture capsules on the order of 100 μm in diameter 
due to the nanometer wide damage created.    This damage may not have enough force to rupture 
capsules or may occur in the space between capsules.   
 One of the challenges for developing small size-scale self-healing systems is to design 
liquid-filled capsules and active particles on the order of 1 m in diameter.  Kessler and et al. 
developed an emulsion surface polymerization of polyureaformaldehyde (PUF) to encapsulate 
DCPD in capsules larger than 20 m in diameter.[38]  Blaiszik et al. demonstrated the synthesis 
of 1.4 m DCPD-filled PUF capsules using a sonication during the emulsification step of the 
DCPD encapsulation process.[35]  While these capsules can be decorated onto glass fibers,[34] 
they do not disperse well in epoxy.   
Silica condensation chemistries have been used to help improve colloid functionality and 
may potentially decrease aggregation of sonicated capsules.  The silica coatings are relatively 
well studied[39-42] and provide a chemically modifiable surface.[43, 44]  The Stöber method is 
particularly useful for coating colloids with a wide variety of functionalities and sizes (Figure 
1.5).[39]   A variety surface functionalities can be added to decrease capsule aggregation, 
including charged groups for charge repulsion or polymer brushes for steric hindrance.[45]  
8 
 
 
Figure 1.5. (a) TEM and (b) SEM of polystyrene particles coated with silica using a modified 
Stöber silica condensation method.  Figure adapted from reference [39]. 
 
 An analogous method for making active particles, particularly Grubbs’ catalyst particles, 
on the order of 1 m in diameter has not been devised yet.  Part of the challenge is that Grubbs’ 
catalyst is susceptible to deactivation by a number of reactive groups.[46-48]  Rule et al. 
developed a scheme for encapsulating the catalyst in wax particles [49] but as the size of the wax 
particles approaches 1 m, aggregation prohibits the use of the encapsulation method.  Gibson 
developed a method for encapsulating Grubbs’ catalyst in polystyrene but did not demonstrate 
well defined catalyst particles.[50]  Regardless, polymer encapsulation is a promising route to 
catalyst encapsulation and has been used frequently in the drug delivery industry to protect and 
slowly release drugs in the human body.  To encapsulate drugs in polymer, researchers use an 
emulsion solvent evaporation procedure.[51-54]  In these procedures, a hydrophobic drug is 
dissolved in an organic solvent with a hydrophobic polymer.  The organic phase is emulsified in 
water and the solvent is driven off leaving behind drug-loaded polymer particles (Figure 1.6).   
 
(a) (b)
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Figure 1.6. Atomic force microscopy (AFM) of polymer nanospheres made with a poly(lactic-co-
glycolic acid) functionalized with polyethylene glycol using an emulsion solvent evaporation 
method.  Figure adapted from [52].  
 
 Another challenge for small size-scale self-healing is to maximize healing response as the 
capsule size decreases.  Rule and co-workers show that, for a given concentration of capsules, as 
the capsule size decreases, the amount of healing agent available in the crack plane decreases 
linearly.[55]  They also show that maximum healing occurs when the crack plane is full and this 
requires a minimum size capsule and capsule concentration for a given damage size.  The typical 
crack widths tested using this work are between 3-10 μm for which capsules larger than 10 μm  
are capable of providing maximum healing.  To demonstrate healing with micron size capsules, 
sub-micron wide damage events need to be tested.  Blaiszik et. al. attained sub-micron wide 
damage events by generating interface damage between fibers and epoxy.[34]  Others reduce 
damage volume by applying pressure across the damaged region.[5, 56]  
 
1.2.2 High Temperature Processing 
High temperature processing is important in the composites industry where high 
temperature, combined with high pressure, can help decrease voids or allow the use of more 
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viscous resins.  For the DCPD and Grubbs’ catalyst system, DCPD is encapsulated in 
polyureaformaldehyde (PUF) capsules, while Grubbs’ catalyst can be used as received.  Kessler 
demonstrated high temperature stability in air for DCPD-filled PUF capsules both with 
temperature ramps and 150 °C isotherms.[4]  Temperature ramps demonstrated that the capsules 
maintained their expected contents after capsule synthesis while 150 °C isotherms demonstrated 
how quickly the capsules lost their contents.  DCPD-filled PUF capsules lose a significant 
quantity of their contents over 2 hours at 150 °C.[4]  To improve upon the thermal stability of 
capsules, Caruso et. al. used a polyurethane (PU) encapsulation method in addition to the PUF 
encapsulation.[57]   
Not as much work has been done to improve the thermal stability of catalyst particles.  
Rule et. al. noted that Grubbs’ catalyst tends to deactivate in epoxy even at room temperature and 
used wax to help protect the catalyst better.[49]  Wax, however, melts above 80 °C so its use is 
limited.   
 
1.2.3 Solution Processing 
 Thermal stability in air provides a rough measure of capsule stability but does not reflect 
conditions that capsules see during processing or use.  Many thermoplastic materials and paints 
require solvents and a solvent evaporation step for the processing of the materials.  Other 
polymers have low viscosity resins and may be considered a solvent in the initial stages of 
processing.  Kumar et. al. described what happens to capsules in solvents used for paints.[14]  
They suggest that core contents diffuse into the paint and, as material is lost, the capsule 
collapses.  Yuan et. al. attempted to quantify healing agent loss from epoxy-filled capsules by 
measuring the quantity of material released into solution.[58] They did not, however, compare 
this to the initial sample weight to determine the percent of sample released. High temperature 
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solvent stability has not been considered but is also important since heat is often required to drive 
off solvents.   
 Drug delivery offers more examples of solvent stability measurements that can be applied 
to capsules and particles.  Researchers in drug delivery engineer drug-loaded devices that can 
release their contents slowly over a long period of time.[53, 54]  In those cases, the capsules or 
particles are dispersed in a solvent for a given time, centrifuged, and the supernatant analyzed to 
determine the amount of drug delivered during exposure to an in vitro environment.  Similar 
methods can be used to determine healing agent loss, as opposed to drug release.   
 
1.3 Statement of Purpose 
 This thesis demonstrates small size-scale self-healing systems for composites and optical 
polymers where the self-healing components are on the order of 1 m or smaller.  Current 
encapsulation methods do not ensure that self-healing components can be well dispersed in a 
polymer matrix and that the components retain their contents during processing.  To build better 
self-healing components at this size-scale, this thesis considers modifications of existing 
encapsulation methods for both liquid healing agents, such as dicyclopentadiene, and solid 
healing agents, such as Grubbs’ catalyst.  For liquid-filled capsules, this thesis addresses the 
encapsulation requirements by employing a silica coating procedure that adds an additional layer 
to previously synthesized capsules.  This layer can act as a base for functionality allowing better 
interaction with the capsules’ environment or it can act as an additional diffusion barrier.  For 
active particles, this thesis addresses the encapsulation requirements by first demonstrating the 
encapsulation of Grubbs’ catalyst in polymer, then modifying the encapsulation with a silica 
coating similar to that used for liquid-filled capsules.   
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This thesis also considers the qualification and quantification of the properties improved 
by a silica modification.  Functionality is demonstrated by successful dispersion of self-healing 
components in polymer matrices.  Stability is demonstrated using a variety of testing methods 
that mimic the liquid-filled capsule and active particle environment.  Current research in capsules 
and particle stability for self-healing do not adequately address the environment of the application 
in which the self-healing components will be used.  As a result, many of the testing methods 
demonstrated are new to self-healing and a comprehensive discussion of these and other stability 
testing methods are discussed in Chapter 6.   
 Finally, within the framework of small size-scale self-healing applications in composites 
and optical polymers, this thesis explores the limitations of employing such a system while 
demonstrating its advantages.  Small size-scale self-healing in epoxy is important for composites 
but also demonstrates the importance of the damage size when healing with capsules on the order 
of 1 m in diameter.  Optical self-healing using a compartmentalized system requires a new 
chemistry and new self-healing concepts that expands the library of self-healing applications.   
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CHAPTER 2: 
MODIFICATION OF CAPSULES VIA SILICA COATINGS 
Parts of this chapter were previously published by the author: 
Jackson, A. C.; Bartelt, J. A.; Marczewski, K.; Sottos, N. R.; Braun, P. V. Silica-Protected 
Micron and Sub-Micron Capsules and Particles for Self-Healing at the Microscale. Macro. Rap. 
Comm. 2010, 31, 82-87. 
 
2.1 Motivation 
While PUF capsules have been successful in a variety of epoxy applications, additional 
shell layers are sought that can improve upon the capsules’ stability and functionality without 
requiring entirely new encapsulation methods.  New applications and processing conditions are 
the primary driving force for this method of modifying the capsules.  In particular, 1.5 μm size-
scale PUF capsules [1] are known to aggregate easily and are not expected to have good stability.  
The lack of surface functionality limits the concentration of micron size PUF capsules that can be 
dispersed in epoxy.  In addition, the high capsule surface area and thin shell wall is not ideal for 
retaining healing agent.  Temperature ramps and high temperature isotherms demonstrate that ca. 
100 m PUF capsules lose a significant quantity of their contents at high temperatures [2, 3] and 
this is expected to be worse at smaller size-scales.  Two size scales of capsules are considered for 
this work: micron size PUF capsules made via a sonication step and large PUF capsules [1] made 
without a sonication step.[2]  The former are approximately 1-2 μm in diameter.  The latter are 
larger than 20 μm in diameter where the exact size of the batch depends on the shear forces 
applied by stir blade during capsule preparation.   
Silica coatings for capsules provide a generalized route for improving both functionality 
and stability.  Silica chemistries are well studied, often utilize mild synthetic conditions,[4-7] are 
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amenable to functionalization,[8, 9] and silica is a potentially good diffusion barrier.  There are a 
variety of ways to add a silica coating to liquid-filled capsules.  These include Stöber 
condensation,[4, 10] fluoride catalyzed condensation,[7] and chemical vapor deposition 
(CVD).[12]  The Stöber condensation and fluoride catalyzed methods are both solution-based 
reactions that require careful engineering of the capsule surface, the solvent used, the catalyst for 
condensation, and ionic environment.  Similar to sizings used in the composites industry, 
functional silanes can be chemically attached to the silica coating to add polymer specific 
functionality to the capsules and this functionality can be used to improve the interface between 
the capsules and polymer matrix.[8, 9]   CVD offers less strict reaction conditions, especially 
where the capsule surface is concerned.  It also requires a fluidized bed reactor setup[12, 13] to 
conformally coat the capsules: without fluidization, contact points between capsules are devoid of 
the silica coating.  This research develops the procedures to coat capsules using each silica 
coating method while exploring the potential improvements in functionality and stability that can 
be gained with a silica coating.   
 
2.2 Surface Chemistry 
Previous research has demonstrated the importance of surface charge on silica 
condensation.  The first steps toward silica condensation are to understand PUF capsule surface 
functionality and to understand how to change the surface functionality.  These capsules are 
prepared using an emulsion surface polymerization method.[1, 2]   As a result, the two 
functionalities that are potentially present on the capsule surface are the amines in the PUF and 
the carboxylic acids present in the emulsifier, ethylene maleic anhydride (EMA).  Work done by 
Blaiszik et al. demonstrates that a negative charge exists on the surface of these capsules above 
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pH 5 suggesting that EMA is the primary functional group exposed on the surface of the 
capsules.[1]   
To change the surface chemistry, layer-by-layer coating methods can be used.[14]  The 
most intriguing method, developed by Graf et al.,[5] used polyvinylpyrolidone (PVP) as a 
universal coating to enhance surface nucleation of silica in a Stöber condensation reaction. PUF 
capsules coated with PVP did not have any characteristic that could confirm the adsorption of 
PVP to the capsule surface.  Silica and other oxides adsorbed to the capsule surface may also 
provide a nucleation center for silica regrowth.  Electroless deposition of gold employs this 
strategy by growing the metal off of gold nanoparticles adsorbed on a surface.[15, 16]  Chang et 
al. also used silica to seed monodisperse silica colloids.[17]  Due to the slightly negative charge 
of PUF capsules, alumina nanoparticles, positively charged below pH 8, can be adsorbed to the 
capsules by electrostatic interactions and potentially act as nucleation spots.  Although samples 
are not sufficiently consistent to obtain zeta potential measurements of the alumina modifications, 
SEM shows visual evidence of alumina adsorption on capsules containing dicyclopentadiene 
(DCPD) (Figure 2.1).   EDAX of the capsule surface confirms that there is a large aluminum 
presence on the capsule surface compared to its background.   
 
Figure 2.1. Surface of DCPD containing PUF capsules that are unmodified (a) and modified with 
alumina particles (b). 
 
2 μm 2 μm
(a) (b)
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2.3 Silica Coating Methods 
2.3.1 Stöber Condensation 
The Stöber condensation chemistry is a well understood route to coating a wide variety of 
colloids with silica.[4]  Stöber conditions require that capsules be dispersed in water, an alcohol, 
ammonium hydroxide, and a silica precursor, usually tetraethylorthosilicate (TEOS).  The first 
challenge to using this method is that the alcohol solvent is a good solvent for many capsule core 
materials, especially dicyclopentadiene (DCPD) which is relevant for this work.  Since a typical 
Stöber reaction requires a minimum of 4 hours to complete, capsules should not lose significant 
amounts of core material during that time.  DCPD capsules, approximately 80 μm in diameter, 
lose all of their contents after 4 hours in ethanol (Figure 2.2b).  To minimize loss, ethanol is 
replaced with a saturated solution of DCPD in methanol.  DCPD capsules in the saturated 
solution remain full after 4 hours (Figure 2.2c).   Despite this improvement, 80 m capsules 
continued to rupture when mechanically mixed in the DCPD-methanol solution suggesting that 
their shell wall is weakened.  PUF capsules 1.5 m in diameter did not rupture during mechanical 
stirring and were used in all Stober silica condensation reactions.  For the successful coating of 
other liquids in PUF capsules without loss of core contents, the core solvent must have a 
saturation concentration in methanol or ethanol.   
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Figure 2.2. (a) Optical microscopy of PUF capsule containing DCPD.  (b) Capsules soaked in 
ethanol for 4 hours and (c) capsules soaked in methanol/DCPD solution for 4hours. 
 
Another challenge towards implementing the Stöber condensation chemistry is to reduce 
secondary nucleation produced during the reaction.  Secondary nucleation occurs when silica 
precursor molecules react faster with themselves than they do with the capsule surface.  These 
secondary nucleations manifest themselves as silica particles less than 200 nm in diameter 
(Figure 2.3).   The particles make it difficult to purify the capsules, often resulting in gelation of 
the final reaction solution.  In addition, the final product contains a high fraction of silica, 
reducing the volume of solvent that can be incorporated into a polymer matrix.   
 
100 μm 100 μm 100 μm
(a) (b) (c)
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Figure 2.3. SEM of capsules produced using an unmodified Stöber procedure.   
 
In a Stöber regrowth method, secondary nucleation can be reduced by either 
functionalizing the capsules with better nucleation sites or by changing reaction conditions to 
slow nucleation reactions in solution.[17-19]  Coating the capsules with PVP or alumina to 
change the surface functionality of the capsules did not decrease secondary nucleations to an 
appreciable extent.   In addition, excess reactants from the capsule synthesis procedure do not 
increase silica secondary nucleation in solution although EMA surfactant does form a porous core 
in the secondary nucleations found in samples where the capsules are not properly centrifuged.  
Instead, the Stöber conditions were the primary source of secondary nucleations.  Here, the key 
factor that reduces secondary nucleation is the concentration of silica precursor in solution.[17, 
19]  At lower concentrations, the precursor molecules are more likely to find a capsule’s surface 
than find other precursor molecules.  Reducing precursor interactions reduces secondary 
nucleation.  By adding the precursor to the capsule solution over an extended period of time with 
a syringe pump, a thick silica shell forms around the capsules without secondary nucleations.   
750 nm
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1.5 m capsules, coated using the Stöber method, are spherical with a rough surface 
(Figure 2.4a).  Capsules are dried by filtering them and washing the sample with ethanol.  The 
dried capsules have no aggregates and are easily broken up on a glass slide or dispersed in water.  
Based on TGA analysis (Figure 2.4b), they contain approximately 50% DCPD.  Microtomed 
cross-sections of the capsules show that the silica shell produced is approximately 75 nm thick 
(Figure 2.4c).   
 
 
Figure 2.4. (a) SEM and (b) TGA of micron size capsules coated using the Stöber method.  (c) 
TEM of the cross-section of the capsules as prepared using a microtoming process.  The core (1) 
is removed during this process while the PUF (2) and silica (3) shells are observed.   
 
There are several factors that limit the use of the Stöber process for coating other liquid-
filled capsules.  First, this system is optimized for DCPD and works because DCPD can form a 
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saturated solution in methanol.  Second, only micron size capsules can be coated using this 
procedure.  Finally, the window for good capsule dispersion in a methanol-DCPD environment is 
relatively small and capsules aggregate with any changes to the PUF chemistry.  These problems 
are avoided by using the fluoride-catalyzed method and, as a result, the Stöber method is not a 
preferred coating method for capsules.   
 
2.3.2 Fluoride-catalyzed Silica Condensation 
 Fluoride-catalyzed silica condensation is an aqueous-based chemistry that uses fluoride 
ions as the catalyst [7, 20] and requires a relatively well controlled ionic environment.  The 
primary advantage of this chemistry is that healing agent loss is inherently limited since capsules 
are not exposed to organic solvents.  Work by Bégu et al. show that lipid micelles can be coated 
with a dense layer of silica using this method.[7]  In that work, tetrabutylammonium fluoride 
(TBAF) serves as the silica condensation catalyst while monobasic sodium phosphate maintains 
an appropriate ionic environment. Other work demonstrates that surface charge and ionic 
environment can both affect the final condensation rate at a surface.[21]  For PUF capsules, 
monobasic sodium phosphate and either ammonium chloride or cetyl trimethylamminum bromide 
give the solution its appropriate ionic environment.   
Capsule size is an important factor in determining the processing conditions required to 
make and collect a free-flowing powder of coated capsules containing healing agent.  During the 
coating step, large capsules frequently rupture when exposed to the shear forces created by a stir 
blade or stir bar.  By mixing the large capsules on a vortexer, the capsule contents remain intact.  
Filtration results in a free-flowing powder of large capsules.  1.5 μm capsules remain stable when 
mixed via stir blade.  However, filtration results in a gel of capsules and silica.  Centrifuging and 
then freeze drying the capsules attains a free-flowing powder.   
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Sonicated DCPD capsules coated with silica are spherical with an average diameter of 1.5 
μm (Figure 2.5a).  TGA and elemental analysis suggest that DCPD is retained in the coated 
capsules at between 55 wt.% and 70 wt.% depending on the synthesis conditions of the sample 
(Figure 2.5b).  TGA analysis also demonstrates that the micron size capsules retain almost all of 
their DCPD after being stored at room temperature for 7 days, providing sufficient time to 
incorporate them into a self-healing polymer.  Figure 5c shows a TEM image of a representative 
cross-section of coated capsules in epoxy prepared by microtome.  The DCPD and part of the 
polyureaformaldehyde (PUF) shell wall are removed during the microtoming process.  The PUF 
shell wall is 20-25nm thick and the silica shell wall is 20-40nm thick.  Based on geometry 
calculations, an ideal capsule should contain 90 wt.% DCPD.  Similar results are obtained for 
capsules containing ethyl phenyl acetate (EPA) and dibutyl phthalate (DBP).   
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Figure 2.5. (a) SEM of DCPD-filled, micron size capsules coated using the Flouride-catalyzed 
condensation method.  (b) TGA traces of micron size coated capsules containing DCPD (1), EPA 
(2), and DBP (3).  (c) TEM shows a representative cross-section of the DCPD-containing 
capsules as prepared using a microtoming process.   
 
As mentioned, silica chemistries are relatively simple and chemical functionalization can 
be added without changing the reaction conditions.  This is important because the silica coating 
can serve as an initiator for polymer brush layers or other similar functionalities which are known 
to decrease the attraction between colloids in solution.[22]  Aminopropyltrimethoxy silicate 
(APTES) reacts with the shell wall when added following the standard silica coating method.  
Zeta potential measurements demonstrate that functionalized capsules are more positively 
charged than the coated capsules without functionalization (Figure 2.6).  At low pH, a capsule 
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functionalized with a dense coverage of amines should have a positive zeta potential.  Because 
the zeta potential is negative for these samples across all pH, it is likely that the capsules do not 
have a high density of functionalization molecules on their surface.   
 
 
Figure 2.6. Zeta potential of silica coated capsules and amine functionalized silica coated 
capsules over a range of pH values.   
 
Large coated capsules range in size depending on the initial batch of capsules used in the 
coating procedure.  Similar to sonicated capsules, microtomed cross-sections of the large coated 
capsules show a conformal silica shell, approximately 20-40nm thick surrounding the PUF 
capsule (Figure 2.7).  The large capsules lose less than 5% of their contents during the coating 
procedure.  The procedure has been demonstrated for ca. 75 μm capsules containing DCPD and 
dibutyl phthalate (DBP).   
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Figure 2.7. SEM (left) of silica coated DBP capsules.  TEM (right) shows a representative cross-
section of 75 μm DBP-containing capsules as prepared using a microtoming process.   
 
2.3.3 Chemical Vapor Deposition 
 Chemical vapor deposition is an alternative method to capsule coating that does not 
require solution processing conditions.  This is beneficial for capsules with relatively weak shell 
walls that cannot survive typical mixing conditions.  For capsules, a fluidized bed reactor (FBR) 
is necessary to achieve full surface coverage.  This technology has been used to coat a variety of 
other colloids.[12, 13]  A successful FBR system disperses airflow through a sample of capsules, 
resulting in fluidization of the capsules and fully exposing capsules to reactants in the gas stream.  
The gas stream is bubbled through silicon tetrachloride or water in a series of cycles that allow 
silica growth at room temperature.[11]  The primary limitation for this method is the size of the 
capsules.  Van der Waals forces between sonicated colloids are too strong for the forces of 
fluidization to break them apart.  As a result, this method is limited to larger capsules.  75 m 
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DCPD capsules coated via FBR-CVD are shown in Figure 2.8.  They are conformally coated and 
lose less than 5% of their contents during work-up.    
 
 
Figure 2.8. TEM of a representative cross-section of 75 μm DCPD-containing capsules as 
prepared using a microtoming process.  
 
2.4 Capsule Stability 
One of the potential advantages of silica coated capsules is improved capsule stability in 
adverse environments.  Capsule stability, in particular stability to loss of core contents by 
diffusion across the shell wall, is important for processing steps and applications where capsule 
are exposed to extreme environments such as high temperatures or solvents.  Past research has 
focused primarily on the thermal stability of capsules.  Temperature ramps from room 
temperature to 600 °C give good qualitative evidence that the core material is encapsulated.  The 
temperature at which weight loss begins is an important indicator for how stable the capsules are: 
capsules that begin to lose contents at higher temperatures are considered more stable.[3, 23]  
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Quantitative measurement of the thermal stability is attained in tests where the capsules weight is 
monitored in a high temperature, 150 °C, environment.[3, 23]  Capsules that lose less mass over a 
two hour period are considered more stable.   
Thermal stability, however, is insufficient alone to quantify the effects of a silica coating 
on capsule coating.  In this section, several other factors are studied to help understand the 
stability of PUF capsules and make a better informed conclusion on effects of silica coatings on 
capsule stability.  Capsule size,  core contents and capsule washing are all important parameters 
that affect capsule stability.  These factors are considered under a variety of new stability tests 
that more appropriately quantify stability for the environments to which the capsules are typically 
exposed than the previously used thermal stability tests.  Under a variety of temperatures, the 
diffusion coefficient of core solvents in PUF is found and extrapolated to room temperature to 
make predictions on room temperature storage.  Capsules are also exposed to high temperatures 
in an epoxy matrix and solvents to better understand how they behave during use and under 
extreme processing conditions.     
 
2.4.1 Modeling the Diffusion Coefficient of Solvents in a Capsule Shell 
The diffusion coefficient of solvents in PUF is calculated using simplified models to 
better compare stability across various samples and extrapolate high temperature stability to room 
temperature stability.   Solvent stability presents the simplest case for modeling solvent loss in 
capsules.  In this case, it is assumed that capsules are dispersed in an infinitely large body of 
solvent and instantaneous perfect mixing occurs inside and outside of the capsule.  In addition, 
flux is assumed to be constant across the shell wall (Figure 2.9a).  Using these assumptions, 
Fick’s first law is simplified according to Equation 2.1 where the flux, J, is a function of the 
31 
 
diffusion coefficient (D), core concentration (Ccore), solvent concentration (CSolv), capsule volume 
(V) and shell wall thickness (w).   
 
 
Figure 2.9. Schematic for assumptions made to calculate the diffusion coefficient for capsules in 
(a) solvent and (b) high temperature.  For solvent stability, the core concentration (C) at time t=0 
sec is 1 while the concentration of core material in the solvent (CS) is approximated as 0 for all 
times since the capsules concentration is dilute.   
 
    
  
  
    
  
    
   
             
  
 Equation 2.1 
 
Given the definition of Flux in Equation 2.2, Equation 2.1 and Equation 2.2 can be 
simplified to find the fraction of contents left in the capsule (c/c0) as a function of diffusion 
coefficient, time (t) and capsule radius (r) (Equation 2.3).   
 
≈
thickness=d
Core:
CC,0=1
Solvent:
Cs ≈ 0
Case I: 
Capsule collapse
(a)
(b)
High temperature
Good Solvent
Case II: 
Bubble formation
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 Equation 2.2 
 
  
           Equation 2.3 
 
During thermal stability experiments, solvent from the surrounding environment does not 
replace the core contents.  Instead, two limiting cases are possible.  If the shell wall is weak, the 
capsule collapses as its contents are lost and the area through which solvent can diffuse remains 
constant.  Assuming changes in pressure are negligible, the capsule contents within the capsule, 
c/c0, are linearly related to D, t, and r (Equation 2.4).   If the shell wall is strong and outside air 
replaces lost contents, the surface area of shell in contact with the core material changes.  
Although physically impossible, if the air forms a bubble shaped like a cone, the capsule contents 
are related to D, t, and r as described in Equation 2.3.  The capsule collapse case forms a lower 
bound while the bubble formation case forms an upper bound for expected thermal stability 
behavior.  Over small times, Equation 2.4 serves as a good approximation to find the diffusion 
coefficient during high temperature isotherms.   
 
 
  
           Equation 2.4 
 
2.4.2 Thermal Stability 
Temperature ramps from room temperature to 600 °C are a good first approximation of 
capsule quality.  The solvent core typically plays the most important role in affecting mass loss 
during a temperature ramp.  The stability of capsules containing DCPD, DBP, and EPA is 
especially relevant in this work.  For capsules made using a 1200 rpm stir rate, DBP capsules 
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(100 μm in diameter) begin to lose their contents at 200 °C while DCPD (120 μm in diameter) 
and EPA (70 μm in diameter) capsules lose their contents at lower temperatures, closer to 100 °C 
(Figure 2.10).  Temperature ramps for 120 μm DCPD capsules coated using the fluoride-
catalyzed silica condensation method show no differences compared to uncoated capsules.  This 
is not surprising, however, since the silica shell wall (20-50 nm thick) is only a small fraction of 
the full shell wall (approximately 200 nm thick).  In addition, although defects in the silica shell 
could not be observed via microscopy, defects cannot be ruled out.   
 
 
Figure 2.10. Temperature ramps for 70 m EPA (dashed line), 100 m DBP (dotted line), and 
120 m DCPD (solid line) capsules made using a 1200 rpm stir rate. 
 
Due to the thinner PUF shell, the silica coating is expected to be more effective for 
sonicated capsules.  However, silica coated, sonicated capsules once again have similar TGA 
traces to uncoated, sonicated capsules (Figure 2.11a).  The only significant difference between 
the uncoated and coated capsules is the quantity of material left at 600 °C which corresponds to 
the silica content in the capsules.  Similar to the large capsules, the encapsulated solvent plays the 
more important role in affecting mass loss during a temperature ramp.  Sonicated EPA and DBP 
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capsules begin to lose their contents at similar temperatures to their large counterparts but silica-
coated, sonicated DCPD capsules do not lose their contents until 200 °C (Figure 2.11b).    
 
 
Figure 2.11. (a) Temperature ramps for coated (solid line) and uncoated (dashed line) sonicated 
DCPD capsules.  (b) Temperature ramps for sonicated EPA (dashed line), DBP (dotted line) and 
DCPD (solid line) capsules.  The average capsule diameter for these samples is 70 m for EPA 
capsules, 100 m for DCPD capsules and 120 m for DBP capsules.   
  
 Isotherms at high temperatures are useful for determining capsule storage stability under 
accelerated conditions.  For ca. 100 m capsules, it is evident that the capsule work-up conditions 
affect stability more than the silica-coating method.  Specifically, capsules washed with ethanol 
are significantly more stable than capsules washed with water only (Figure 2.12a).  Mass loss 
from capsules washed with water is similar to the mass loss from capsules prepared by 
Kessler.[3]  Consistency of capsule work-up conditions is important for quantifying capsule 
stability and, under the same work-up conditions, no improvements are observed between 
uncoated and coated capsules.  120 m DCPD capsules coated using the fluoride-catalyzed silica 
condensation chemistry perform similarly to capsules washed in ethanol but DCPD capsules 
coated using the FBR-CVD method do not perform nearly as well (Figure 2.12b).   
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Figure 2.12. (a) 150 °C isotherms for 100 μm DCPD uncoated capsules rinsed with water 
(dashed line) or ethanol (solid line).  (b) 150 °C isotherms for 100 μm DCPD capsules coated 
using either the fluoride-catalyzed silica condensation chemistry (dashed line) or using the FBR-
CVD method (solid line).  Dotted lines correspond to the temperature profiles of the TGA runs.   
 
Unexpectedly, sonicated capsules are more stable than large capsules based on 150 °C 
isotherm experiments (Figure 2.13).  As discussed earlier however, these capsules contain 50-70 
wt% DCPD when geometry calculations suggest that they should contain closer to 90 wt% 
DCPD.  In addition, the ratio of the sonicated capsule shell thickness to its radius, approximately 
0.067, is significantly higher than the ratio for large capsules, 0.005.  This is particularly 
interesting because if content loss is driven by pressure changes within the capsules, capsule 
stability should change with the ratio of capsule thickness to radius.  Imaging of capsules 
subjected to high temperatures suggests that the core material does undergo a pressure change and 
that this pressure change is enough to increase the capsule radius for large capsules.  It is unclear, 
however, how this should affect stability.  A simple argument may also be made that sonicated 
capsules aggregate at higher temperatures making the diffusion of DCPD out of the mass of 
capsules slower than the diffusion of DCPD out of a mass of larger capsules.  Although 
temperature isotherms were measured up to 210 °C for coated and uncoated sonicated capsules, 
PUF begins to degrade at 150 °C making this data purely academic.   
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Figure 2.13. High temperature isotherms at (a) 150 °C, (b) 180 °C, and (c) 210 °C of DCPD-
filled PUF capsules coated with silica using the fluoride-catalyzed silica condensation chemistry.   
 
Capsules rarely see high temperature exposure during storage and, as a result, the 
diffusion constant of core material in PUF is extrapolated to room temperature to better 
understand stability.  At 60 °C, DCPD loss from uncoated and coated PUF capsules is still similar 
and the more important factor for stability at 60 °C is still the capsule preparation (Figure 2.14).  
Instead, to understand stability at lower temperatures, research focused on the core material.  
(Figure 2.15).  Between EPA and DBP, solvents with similar molecular structure, DBP is more 
stable at all temperatures.  Assuming an Arrehnius dependence on temperature, the diffusion 
coefficient of DBP in PUF at room temperature is calculated to be 10
-14.8
 cm
2
/sec while the 
diffusion coefficient for EPA is calculated to be 10
-12.7
 cm
2
/sec.  These diffusion coefficients 
correspond to loss of 50% of the capsule’s healing agent over 140 days and over 1 day 
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respectively.  This does not agree with the capsule storage stability found in a lab setting.  
Specifically, EPA capsules retain a significant quantity of their contents at room temperature over 
1 day.  This is potentially a result of saturation of EPA in room temperature air that limits 
evaporation of EPA from the capsule surface.  Without evaporation, the solvent concentration 
gradient across the capsule decreases and no further solvent leaks.   
It is important to note that at low temperatures, DBP capsule stability, in addition to the 
stability of other capsules, may be limited by solvent evaporation as opposed to solvent diffusion 
across the capsule shell wall.  During 50 °C isotherm experiments, weight loss from a sample of 
DBP liquid is similar in magnitude to the weight loss from DBP capsules.  Weight loss at higher 
temperatures is greater for DBP liquid than DBP capsules confirming that weight loss is limited 
by diffusion at those temperatures.  Indeed, DBP capsules, and other capsules, tend to aggregate 
after a week of storage as solvent on the capsule surface initiates capillary forces between 
capsules.   
 
 
Figure 2.14. 60 °C Isotherms for 70 m DCPD capsules washed with water (1), washed with 
ethanol (2) and coated with silica (3).   
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Figure 2.15. Inverse temperature vs. the log of the diffusion coefficient for 70 m EPA capsules 
(squares), 100 m DCPD capsules (diamonds), and 120 m DBP capsules (triangles).  All 
capsules are washed with ethanol.  The shell thickness is approximated as 200 nm.  Trendlines 
shown.   
 
An unexpected result from the isothermal experiments is that the stability of DCPD 
capsules is consistently better than the stability of EPA capsules.  This is interesting because 
DCPD has a lower boiling point, higher vapor pressure at 20 °C, and smaller molecular weight 
than EPA.  While oligomerization of the DCPD molecules via a Diels-Alder reaction can increase 
the volatility of DCPD, this is unlikely below 100 °C over short times.[24]  Instead this highlights 
the importance of the interaction between solvent molecules and the capsule shell wall.   
Exposure of capsules to high temperatures is more likely to occur when the capsules are 
in a polymer matrix.  Micro CT images of 80 m uncoated DCPD capsules in epoxy show the 
effects of high temperature exposure for various times (Figure 2.16) at 80 °C.  Bubbles form in 
the capsules very quickly, within 2 days, but remain the same size over a week.  The plateau 
corresponds to approximately 6% volume loss.  Given the thermal expansion for a typical liquid, 
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gasoline for example, is approximately 10
-3
 K
-1
, the volume loss is consistent with the volume 
expansion of a liquid from 25 °C to 80 °C.  It is hypothesized that the temperature increase in the 
sample increases pressure within the capsules driving diffusion of the solvent into the epoxy 
matrix.  Upon reduction of the temperature from 80 °C to room temperature, the solvent contracts 
back to its original volume leaving bubbles corresponding to solvent lost in the polymer matrix.  
No further analysis was done to compare uncoated capsules to silica coated capsules since short-
term DCPD loss is more dependent on volume expansion of the solvent rather than diffusion 
across the shell wall.    
 
  
Figure 2.16. Slices of a reconstructed CT scan of 10 wt% DCPD capsules in epoxy after (a) 0 
days and (b) 8 days at 80 °C.  Average weight loss over time as calculated from the geometry of 
capsules scanned by micro CT.  Capsules have an average diameter of 140 m. 
 
2.4.3 Solvent Stability 
Solvent stability is especially important for self-healing materials made by solvent 
casting a thermoplastic polymer matrix.  In proof of concept experiments, 30 m chlorobenzene 
capsules consistently lost their contents after approximately 4 hours in ethanol corresponding to a 
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diffusion constant of approximately 10
-12
 cm
2
/sec (Figure 2.17).  This is relatively low compared 
to other solvents in polymer but similar to the diffusion coefficient calculated for DCPD capsules 
in thermal experiments (Table 2.1).  Solvent stability of DCPD capsules could not be quantified 
as a result of a number of factors including inaccurate measurement of the initial DCPD content 
in the capsules and loss of the standard due to evaporation.   
 
 
Figure 2.17. Weight loss from chlorobenzene capsules in ethanol as a function of time.  Capsules 
have an average diameter of 30 m and a shell wall thickness of 130 nm as measured by SEM.   
 
Solvent Polymer Diffusion Coefficient 
(cm
2
/sec) 
Reference 
DCPD PUF 10
-13
 at 50 C Thermal Stability 
Chlorobenzene PUF 10
-12
 at RT, in ethanol Solvent Stability 
Water PVC 10
-8
 at RT [25] 
Propane Cellulose nitrate 10
-11
 at RT [25] 
 
Table 2.1. Diffusion coefficients of various solvents in polymers.   
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Similar to thermal stability experiments, the core material is more important than the 
silica coating.  As discussed in chapter 5, DBP and EPA capsules are important for thermoplastic 
self-healing of PMMA and, as a result, should be stable to the solvent casting techniques used to 
manufacture the self-healing components.  One important problem with this system is that visual 
observations suggest that large EPA capsules, 70 μm in diameter, lose all of their contents during 
the processing of the films.  Indeed, qualitatively, EPA capsules lose a significant portion of their 
contents when exposed to anisole and heated at 90 °C for 1 hour (Figure 2.18a) as measured by 
GC.  DBP capsules, 100 m in diameter, however, retain all of their contents under the same 
conditions (Figure 2.18b).  The trend is similar for 1.5 μm diameter capsules (Figure 2.18c,d).  
This is an important factor for choosing DBP as a healing agent as opposed to EPA for 
thermoplastic self-healing of PMMA films.   
 
Figure 2.18. GC traces of filtered solution from DBP capsules or EPA capsules dispersed in 
anisole (1 wt.%) with a DCPD standard at 90°C for 1 hour (black lines).  Controls of 
unencapsulated solvent dispersed in anisole (1 wt.%) with a DCPD standard are shown for 
qualitative comparison (gray lines).   
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2.5 Conclusions 
Silica chemistries are useful for applying an additional functional layer to PUF capsules.  
Stöber chemistry, fluoride-catalyzed chemistry, and chemical vapor deposition techniques coat 
capsules with 20 – 50 nm of silica.  The Stöber chemistry successfully coats micron size capsules 
but damages larger capsules.  The CVD method successfully coats large capsules but sonicated, 
ca 1.5 μm, capsules cannot be dried effectively to be introduced into the FBR setup with 
aggregation.  Aggregates lead to an incomplete coating of the capsules.  The fluoride-catalyzed 
chemistry condenses silica onto both micron size capsules and larger capsules successfully and is 
a promising generalized method to coat a variety of PUF capsules with a functionalizable surface.  
The most important result for this coating process is that coated micron size capsules dry to a 
powder of individual capsules without aggregates, something that uncoated micron size capsules 
cannot do.   
The silica shell is also expected to add an extra diffusion barrier around capsules.  
However, silica coated capsules do not consistently retain more contents than their uncoated 
counterparts.  Improvements in stability can more easily be obtained by changing the capsule 
drying procedures and the type of core material used.  DCPD capsules rinsed in ethanol show 
remarkably improved thermal stability than those rinsed with water.  More importantly, both 
thermal and solvent stability improve when increasing the molecular size of the solvent used. 
Relevant to epoxy applications, capsules only lose 6 vol% over 24 hours at 80 °C and no further 
loss occurs after 1 week.  This weight loss corresponds to a pressure increase in the capsule at 
high temperature due to volume expansion.  Relevant to solvent casting applications, capsules 
containing DBP retain a significant portion of their contents in anisole after 1 hour at 90 °C 
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whereas capsules containing EPA lose a significant portion of their contents under similar 
conditions.  
 
2.6 Experimental 
2.6.1 Materials 
Ammonium chloride was purchased from sigma.  Monobasic sodium phosphate and 
sodium chloride were purchased from fisher.  Brij 97, Resorcinol, urea, dibutylphthalate (DBP), 
ethyl phenyl acetate (EPA), formaldehyde solution, tetrabutyl ammonium fluoride (TBAF), 
ammonium chloride, glycidoxypropyltrimethoxy silane (GLYMO), and tetraethylorthosilicate 
(TEOS) were purchased from sigma-aldrich.  Formaldehyde was purchased as a 37.5 wt.% 
solution and TBAF was purchased as a 75 wt.% solution in water.  For all experiments, 1 mL 
TBAF was diluted with 100 mL Millipore water.  Ethylene maleic anhydride (EMA) surfactant 
was donated by vertellus (chemical name ZeMac).  For all experiments, a 2.5 wt.% solution of 
EMA in water was made and used.  Methyltriethoxy silane (MTMS), cetyltrimethylammonium 
bromide (CTAB), dicyclopentadiene (DCPD), and anisole were purchased from Acros.  
Aminopropyltriethoxy silane (APTES) and silicon tetrachloride was purchased from Gelest.   
 
2.6.2 Capsule Manufacture 
Capsules were fabricated using the emulsion surface polymerization methods described 
previously.[1, 2]  Two sizes were considered in this work: small capsules (1.5 μm in diameter) 
and large capsules (approximately 75 μm in diameter). Briefly, ammonium chloride, resorcinol, 
urea and EMA surfactant were dissolved into water and mixed under mechanical stirring.  A 
hydrophobic solvent, DBP, EPA, or DCPD was added to the water phase and emulsified.  
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Emulsification for large capsules was accomplished using a stir blade setup between 600 rpm and 
1500rpm while emulsification for micron size capsules was accomplished using a stir blade setup 
at 900 rpm.  For micron size capsules, sonication was employed to decrease the emulsion 
droplets’ size.  Formaldehyde was then added, starting the reaction.  The reaction temperature 
was increased to 55 °C at 60 °C/min and held at 55 °C for 4 hours.  Large capsules (75 μm) were 
filtered to remove excess reactants while small (1 μm) capsules were centrifuged to remove 
reactants.   
 
2.6.3 Stöber Condensation 
 The Stöber condensation method was only used with 1.5 μm DCPD capsules.  A 
schematic of the setup used is shown in Figure 2.19 and is based on work by Giesche.[18]  Three 
solutions were prepared as described in Table 2.2.  Solution C was mixed with 20 mL of 
sonicated capsules after centrifugation of the sample (4500 rpm, 20 minutes). This solution was 
stirred using a mixer blade in a reaction vessel at 600rpm.  Solution A and Solution B were added 
to 60 mL syringes and pumped into solution C at 0.022 mL/min.  If a functionalization was 
desired, the epoxide functionalization GLYMO for example, at 0.9 mL or the silane was added 
after 24 hours.  The reaction continued for another 12 hours after the addition of the 
functionalization silane.  The final sample was filtered and washed with ethanol only.   
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Figure 2.19. Schematic of the Stöber condensation reaction setup.  Two solutions, one containing 
solvent and catalyst (1) and the other containing solvent and silica precursor (2) are injected into a 
flask containing solvent, catalyst and capsules (3).  The solution in the flask is stirred at 600 rpm.   
 
Solution Saturated solution of 
DCPD in methanol 
(mL) 
Water 
(mL) 
Ammonium 
hydroxide (mL) 
TMOS 
Solution A 20 0.5 1.9 0 
Solution B 20 0 0 0.3 
Solution C 30 0.4 1.4 0 
     
 
Table 2.2. Quantities of reactants added to the solutions required for Stöber silica condensation 
on capsules.   
 
2.6.4 Fluoride-catalyzed Condensation 
Sonicated capsules were coated with silica by first removing excess reactants through 
centrifugation (2 times at 4500 rpm for 20 minutes).  Monobasic sodium hydroxide (0.2 g), 
1
2
3
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Ammonia chloride (0.05 g) and dilute TBAF solution (12 mL) was mixed in water (20 mL).  
Capsules (~8 % w/w in 40 mL of water) were mixed into this solution and stirred using an 
impeller blade at 500 rpm.  Finally, TEOS (1 mL) was added and the reaction was stirred for 24 
hours.  Functionalization (optional, APTES or MPTMS, 0.1 mL) was added and the reaction 
allowed to continue for another 24 hours.  The coated capsules were first centrifuged, and then 
freeze dried for 3 days.   
 To coat large capsules, a solution was prepared with CTAB (0.05 g), Monobasic sodium 
phosphoric acid (0.1 g), TBAF solution (6 mL), millipore water (20 mL), and capsules (0.7 g).  
This solution was vortexed on low for 5 minutes before adding TEOS (0.5g).  The reaction 
continued under low vortexing for 24 hours.  The capsules were finally filtered and washed with 
ethanol.   
 
2.6.5 FBR-CVD 
 FBR-CVD was used to coat only large capsules, 50-300 μm.  A typical CVD setup is 
shown in Figure 2.20.  The setup allows Nitrogen, water rich nitrogen, and precursor (silicon 
tetrachloride) rich nitrogen to flow through a 2.54 cm diameter frit containing capsules.  The 
initial nitrogen flow rate was increased until fluidization occurred, usually 25 cc/sec.  To begin 
the CVD step, nitrogen flow was turned on for 30 seconds followed by flow of water rich 
nitrogen for 2 minutes.  Subsequently, a full cycle was completed with each reactant gas stream 
run through the FBR as described in Table 2.3.  For this work, 3 cycles were completed.   
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Figure 2.20. Schematic of FBR-CVD setup.   
 
Step Nitrogen (sec) Water-rich Nitrogen 
(sec) 
Precursor-rich 
Nitrogen (sec) 
Step 1 30 0 0 
Step 2 0 30 0 
Step 3 30 0 0 
Step 4 0 0 30 
Step 5 30 0 0 
 
Table 2.3. Steps in 1 cycle for the FBR-CVD setup.   
 
2.6.6 Capsule Analysis 
DCPD capsules were analyzed as follows.  Shell morphology was determined by SEM 
(Philips XL30 ESEM-FEG) and TEM (Philips CM200).  The shell wall was analyzed more 
closely by sectioning the samples via a microtome process followed by TEM analysis.  Fill 
content of the capsules was determined using thermal gravimetric analysis (TGA) and elemental 
analysis.  TGA was performed using a Mettler-Toledo TGA 851e under nitrogen atmosphere and 
Water 
Bubbler
SiCl4
Bubbler
N2
FBR
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a heating rate of 10 °C min
-1
.  DCPD content was calculated by comparing the weight loss from 
PUF made without solvent to weight loss from capsules.  The shoulders at 200 °C and 400 °C are 
indicative of the quantity of DCPD contained in the capsules (Figure 2.21).  Elemental Analysis 
was performed on a CE440 by Exeter Analytical.  The percent carbon (WC), hydrogen (WH), and 
nitrogen (WN) were obtained from this method and plugged into Equation 2.5 and Equation 2.6 
to find the percent PUF (WPUF) and DCPD (WDCPD).  This equation has been derived previously 
[1, 3] and is based on the amount of carbon, hydrogen, and nitrogen in polyureaformaldehyde 
(PUF) and DCPD.   
 
               Equation 2.5 
                           Equation 2.6 
 
 
Figure 2.21. Degradation of PUF as measured by TGA.   
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 Micro CT scans were taken on an XRadia MicroXCT-200.  The weight loss from 
capsules was determined by measuring the diameter of bubbles in the capsules and the diameter 
of the respective capsules.  The ratio of the cubes of the diameters was taken to be the volume 
loss from the capsules.   
Solvent stability of capsules was tested by dispersing capsules in solvent with a standard.  
Chlorobenzene capsules were dispersed in ethanol with a DCPD standard.  DCPD capsules were 
dispersed in ethanol with a chlorobenzene standard.  DBP and EPA capsules were dispersed in 
anisole with a DCPD standard.  All capsule concentrations and standard concentrations were 1 
wt% capsules in solvent.  After mixing the capsules on a vortexer at a low setting for a period of 
time, the capsules were filtered using a 0.45 μm pore size polytetrafluoroethylene syringe filter.  
The contents were then run through gas chromatography (GC) and the area of solvent peaks used 
to calculate the quantity of solvent remaining in the solvent. The area of the capsule solvent peak 
was normalized to the area of the standard with known concentration and no capsules.  GC was 
run on a Hewlett Packard 5890 Series II with split injector and flame ionization detector.  The GC 
run proceeded from 100 °C to 250 °C at 10 °C/min.   
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CHAPTER 3 
POLYMER PARTICLES CONTAINING GRUBBS’ CATALYST 
Parts of this chapter were previously published by the author: 
 Jackson, A. C.; Bartelt, J. A.; Marczewski, K.; Sottos, N. R.; Braun, P. V. Silica-Protected 
Micron and Sub-Micron Capsules and Particles for Self-Healing at the Microscale. Macro. Rap. 
Comm. 2010, 31, 82-87.
 
 
3.1 Motivation 
A new encapsulation scheme to protect Grubbs’ catalyst is sought to improve the 
functionality and stability of current catalyst particles used in self-healing materials, especially 
for small size-scale and high temperature self-healing applications.  To date, Grubbs’ catalyst has 
been the primary component, combined with dicyclopentadiene (DCPD) capsules, for mechanical 
self-healing in epoxy.  The primary challenge with using Grubbs’ catalyst is that it deactivates 
upon reaction with amines and alcohols in epoxy resins forming a hydride or ruthenium metal.[1-
3] The relevant epoxy system this work focuses on contains the epoxy resin EPON 828 
(diglycidal ether of bisphenol A) and the epoxy hardener DETA where DETA is the primary 
cause for deactivation.  Previously, a wax protection scheme has been used to improve the 
healing efficiency of self-healing composite where both capsules and catalyst particles are larger 
than 20 μm in diameter.[4]  For small size-scale applications, however, wax particles less than 5 
μm aggregate and are no longer a viable option for catalyst protection.   
Encapsulating Grubbs’ catalyst in polymer particles offers a means for building stable 
sub-micron catalyst particles.  Previous work showed that Grubbs’ catalyst encapsulated in 
polystyrene allows recovery of the catalyst in industrial applications.[5]  While these particles are 
not clearly defined and therefore not useful in self-healing materials, the research does highlight a 
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promising route for catalyst encapsulation.  Researchers in drug delivery successfully encapsulate 
drugs in polymer particles less than 5 μm using an emulsion solvent evaporation method.[6-8]  
Due to their elevated melting point compared to wax, polymers also offer potential improvements 
in thermal stability for catalyst encapsulation.  Using a similar procedure, this chapter 
demonstrates the successful synthesis of polymer-protected catalyst particles on the order of 1 μm 
in diameter.  The chapter also demonstrates potential improvements in thermal stability for 
particles larger than 15 m in diameter.  In particular, polystyrene (PS) is chosen as the 
encapsulant since it dissolves readily in DCPD. 
 
3.2 Sub-micron Polystyrene Particles Containing Grubbs’ Catalyst 
 Several factors in the emulsification process are investigated to optimize the procedure 
for making sub-micron polymer protected catalyst particles.  In the emulsion solvent evaporation 
scheme, PS and Grubbs’ catalyst are dissolved in methylene chloride and the solution is 
emulsified in water with the help of a surfactant.  The surfactant can affect the morphology of the 
particles.  A high molecular weight polymer surfactant, EMA for example, forms collapsed 
polymer shells while a shorter molecular weight polymer surfactant, Pluronic 127 or CTAB for 
example, forms spherical particles.  CTAB is chosen as an appropriate surfactant for sub-micron 
catalyst particles since it has no groups that deactivate the catalyst.  The emulsification method is 
also important for producing sub-micron particles.  Similar to the procedure used to make 1.5 μm 
DCPD capsules, sonication is also employed here to reduce the emulsion size sufficiently.   Once 
emulsified, the solvent is removed by evaporation with the assistance of nitrogen flow.   
 The resulting sample contains PS-protected catalyst particles with an average diameter of 
1.5 μm (Figure 3.1a) although the standard deviation was large, 0.7 μm and a few particles exist 
that are larger than 5 μm.  Rheology demonstrates that the catalyst particles remain active after 
synthesis.  In rheology experiments, catalyst (as opposed to the catalyst particle) concentration 
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was kept constant at 0.0167 g mL
-1
 in DCPD.  This value is consistent with the concentration of 
catalyst in a crack plane reported in previous literature.[4, 9]  The gel time for the catalyst-
containing polymer particles, 30 minutes, is similar to the gel time of unprotected catalyst in 
DCPD (Figure 3.1b).  This gel time is faster than the kinetics described by Kessler et al. [10] 
because the concentration of catalyst used here is an order of magnitude higher than the 
concentration used in the work by Kessler.   
 
Figure 3.1. (a) SEM of polystyrene-protected catalyst particles. (b) The gel time of the polymer-
protected catalyst particles (solid line) compared to that of the as-received Grubbs’ catalyst 
(dotted line) as measured by rotating plate rheometry. 
 
When incorporated into epoxy, the PS-protected catalyst particles react to form a 
ruthenium hydride that is yellow in color compared to the purple color of active catalyst.  This 
hydride is unable to polymerize DCPD.  A variety of individual changes to the synthesis 
procedure results in no improvements to particle stability.  Molecular weight is important to the 
extent that higher molecular weight polymers swell more slowly in good solvents [11] and, as a 
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result should minimize swelling by components in the epoxy matrix.  However, increasing the 
molecular weight of the PS from 35 kDa to 120 kDa did not improve stability.  A silica coating, 
made via the fluoride-catalyzed silica-coating method described in Section 2.3.2, is expected to 
add an extra diffusion barrier to protect the particles from deactivating species but is insufficient 
alone.  The type of polymer is import to the extent that epoxy and DETA swell some polymer 
better than others.  Polymethylmethacrylate (PMMA) proved the most promising but was also 
insufficient alone.  In addition, PMMA doesn’t dissolve in DCPD making the catalyst 
inaccessible in a purely PMMA-protected catalyst particle. 
A composite particle containing high molecular weight PS, PMMA, and silica proved to 
be most effective at protecting the catalyst in epoxy.  The particles, after freeze drying, form a 
free-flowing powder with few aggregates.  The composite particles are approximately 0.4 μm in 
diameter and have a uniform 20 nm thick shell of silica surrounding them (Figure 3.2).  Based on 
SEM analysis, the particle size distribution is 0.4 ± 0.3 μm.  The PMMA is expected to phase 
separate in the particles and either form a second barrier or improve the interface between the 
polystyrene and silica.  SEM imaging shows a dumbbell shape to many of the particles suggesting 
that the PMMA does partially coat the PS.  To demonstrate the activity of catalyst within the 
particles, the synthesized particles are prepared for 
1
H NMR by etching the silica shell with HF 
solution and then dissolving the remaining particles in CDCl3.  Because there are many peaks 
from the polystyrene and polymethylmethacrylate, the presence of the carbene hydrogen peak at 
20ppm is the best qualitative evidence for active catalyst in the particles.[1, 3]  This peak is 
present in the spectrum of as-received Grubbs’ catalyst, Grubbs’ catalyst encapsulated in 
polystyrene, and the etched catalyst particles (Figure 3.2c).  When as-received catalyst is 
dispersed in solvent containing an amine, the catalyst deactivates.  The H
1
 NMR spectrum of this 
deactivated catalyst sample shows no peak at 20ppm.  The etched catalyst particles are also 
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dispersed in DCPD to directly test their activity.  After 30 minutes, the mixture gels verifying 
catalyst activity.   
 
 
Figure 3.2. The morphology of the core-shell catalyst particles as observed via (a) TEM and (b) 
SEM.  (c) H
1
 NMR spectrum of as received Grubbs’ catalyst (1), catalyst in polystyrene (2), and 
etched particles of catalyst in polystyrene, poly(methyl methacrylate) and silica (3).   
 
3.3 PS-protected Grubbs’ Catalyst for Thermal Stability 
 Because polystyrene’s glass transition temperature (~100 °C) is higher than the melting 
point of wax (70-80 °C), 10-100 μm in diameter polymer protected catalyst particles are expected 
to retain more active catalyst at high temperatures. To build 10-100 μm PS particles without 
catalyst, an emulsion of PS and solvent, in this case toluene in water is produced and the solvent 
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evaporated to build PS particles.  Unlike sub-micron capsules, the sonication step is removed and 
a mixer blade is used to create an emulsion with larger droplet size.  However, when synthesizing 
larger PS particles containing the catalyst the resulting sample is an aggregated mass of polymer 
and catalyst.  To make well dispersed particles, a quench bath, made of methanol and water, is 
required and removes sufficient solvent from the emulsion and eliminate aggregation in the 
sample by increasing the solubility of the hydrophobic solvent in water.   No further protection is 
necessary at this size scale.   
 The final catalyst-containing particles are purple and spherical in shape.  Changing the 
stir rate of the initial emulsion changes the particle size as long as the quench bath stir rate is kept 
low, typically 400 rpm.  Figure 3.3 shows the particle size as a function of stir rate for the initial 
emulsion solution and the quench solution.  PS protected catalyst particles maintain their purple 
color after synthesis and remain active when dispersed in DETA, the primary deactivating species 
in an epoxy resin.   NMR of the final sample shows a carbene peak near 20 ppm, indicative of 
active Grubbs’ catalyst.  When dispersed in DCPD, the PS-protected catalyst gel time, 40 minutes 
as measured by rheology, is comparable to the gel time of wax-protected catalyst (Figure 3.4).  
This is shorter than the gel time of as-received catalyst in DCPD and is expected due to the slow 
dissolution time of the crystallized catalyst in DCPD.   
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Figure 3.3. (a) Particle size as a function of initial emulsion stir rate with a constant quench 
solution stir rate of 400 rpm.  (b) Particle size as a function of the quench solution stir rate with a 
constant initial emulsion stir rate of 400 rpm.   
 
 
Figure 3.4. Viscosity of solutions of DCPD containing (1) unprotected catalyst, (2) catalyst in 15 
μm wax particles, and (3) catalyst in 15 μm PS particles.   
 
To test the PS particles for their resistance to deactivating species, the particles are 
dispersed in a solution of DETA and water.  After exposing the PS-protected catalyst particles to 
DETA, the gel time increases slightly but remains less than 1 hour.  This is also true for wax 
protected catalyst particles.  The primary difference between PS-protected particles and wax-
protected catalyst particles is the temperature at which the particles begin to coalesce and cannot 
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be collected from the DETA solution.  Wax-protected particles fall cannot be collected for 
rheology tests above 35 °C while PS-protected catalyst particles remain intact until 65 °C.  When 
cured in epoxy at 50 °C, the wax-protected particles dissolve into the epoxy matrix while PS 
particles remain relatively intact (Figure 3.5).   
 
 
Figure 3.5. (a) PS-protected catalyst particles and (b) wax-protected catalyst particles dispersed 
in epoxy resin after curing at 50 °C for 24 hours.   
 
3.4 Conclusions 
Grubbs’ catalyst is successfully encapsulated in polystyrene using an emulsion solvent 
evaporation procedure with minimal catalyst deactivation.  Sub-micron PS-protected catalyst 
particles are important for small size-scale self-healing as a complimentary healing agent to the 
coated 1.5 μm diameter capsules discussed in Chapter 2.  Sub-micron PS particles are made using 
sonication to emulsify a solution of catalyst, PS and solvent in water.  The final particles form a 
dried powder with few aggregates.  However, sub-micron PS particles do not provide sufficient 
protection at the sub-micron size-scale to be incorporated into epoxy.  The sample turns yellow 
during the epoxy curing cycle as a result of the reaction between the catalyst and amines in the 
epoxy hardener, DETA.  Instead a composite particle containing PS, PMMA, catalyst, and a silica 
shell is developed and maintains its active, purple color when incorporated in epoxy.  10-100 μm 
5 μm5 μm(a) (b)
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diameter PS-protected catalyst particles are important for high temperature self-healing 
applications using the DCPD-Grubbs system.  These particles maintain their activity in a solution 
of DETA up at up to 65 °C.  The PS particles remain solid in epoxy at 50 °C while wax particles 
of similar size dissolve into the epoxy resin.   
 
3.5 Experimental 
3.5.1 Materials 
 Dicyclopentadiene (DCPD) was purchased from Alfa Aesar (90+%, stab. with 150-
200ppm p-tert-butyl catechol).  The DCPD was distilled to remove cyclopentadiene and any 
oligomeric units that might be present.  Grubbs‘ catalyst, wax (mp=58-62 °C), and Polystyrene 
(PS, MW=280000 and MW=35000) were purchased from Aldrich.  Grubbs‘ catalyst was kept in 
a nitrogen glovebox until use.  Ethylene maleic anhydride copolymer was donated by Zeeland 
chemicals (EMA, MW=400000).  This was used as a 2.5 % w/w solution in water.  Pluronic was 
purchased from BASF.  polymethylmethacrylate (PMMA, MW=120000), 
cetyltrimethylammonium bromide (CTAB), tetraethylorthosilicate (TEOS), and 
tetrabutylammonium fluoride (TBAF, 75wt% in water) were purchased from Sigma.  TBAF was 
diluted to 0.75wt% for use.  EPON 828 was purchased from Miller Stephenson and 
diethylaminetriamine (DETA) was received from Dow Chemical. 
 
3.5.2 Polymer-protected Catalyst Particles 
Composite polymer particles containing Grubbs’ catalyst were prepared using an 
emulsion solvent evaporation technique similar to those described in literature.[6, 7]  First, CTAB 
(0.4 g) and dilute TBAF (18 mL) were dissolved in water (120 mL) at room temperature and 
stirred with a stir bar at medium speed.  Next, PS (MW=35000, 0.8 g), PMMA (0.4 g), and 
61 
 
Grubbs’ catalyst (0.08 g) were dissolved in methylene chloride (16 mL).  For composite particles, 
PS (0.8 g) and catalyst (0.08 g) were dissolved in methylene chloride (16 mL).  This organic 
phase was poured into the aqueous phase, emulsified for 1 minute via stir bar, and then sonicated 
for 30 seconds.  The emulsion was stirred overnight with nitrogen flowing over the sample to 
assure evaporation of the methylene chloride.  To add a silica coating, TEOS was added to the 
solution and allowed to react for 1 day.  The final particles were centrifuged and then freeze dried 
for 4 days affording a dry powder.   
Grubbs’ catalyst particles larger than 5 μm were formed in a 2 part synthesis.  In the first 
part, an oil in water emulsion was created with PS (MW=280000, 0.45 g), toluene (4.5 mL) and 
catalyst (0.045 g) in the oil phase.  Water (40 mL) and pluronic 127 (0.05 g) formed the water 
phase.  The solution was emulsified via mixer blade.  After 2 minutes of emulsification, the 
solution was transferred to a quench bath containing methanol (110 mL), water (50 mL), and 
pluronic 127 (0.1g).  The quench bath was stirred, via mixer blade, over night with nitrogen flow 
over the sample to help remove the solvent.  The final particles were dried by filtration and 
washing the particles with water.  The procedure is scaleable and has been successfully attempted 
at 3x the quantities listed.   
 
3.5.3 Catalyst Particle Analysis 
Grubbs’ catalyst particles were analyzed as follows.  Particle morphology was 
determined by SEM (Philips XL30 ESEM-FEG) and TEM (Philips CM200).  For rheology 
experiments, catalyst (as opposed to the catalyst particle) concentration is kept constant at 0.0167 
g mL
-1
 DCPD.  This assumes a sample with 3 μm crack width and 5 % w/w 10 μm catalyst 
particles. This mixture was dripped onto a rotating plate geometry (25 mm diameter) set to have a 
200 nm gap.  Viscosity was measured every minute at a constant frequency (5 Hz).  Gel time was 
determined by the peak in tan δ (loss modulus divided by the storage modulus).  Because silica 
coated particles did not dissolve in organic solvents, the particles were etched in a solution of 20 
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% w/w HF in water for NMR and qualitative gel tests.  NMR spectra were taken of various 
catalyst particles dissolved in deuterated methylene chloride with a trimethoxybenzene standard.  
In order to determine a qualitative gel time for the coated catalyst particles, the particles were 
etched and mixed into DCPD at 0.0167 g mL
-1
 DCPD.  Due to the number of peaks for the other 
materials in the catalyst particles, no peaks could be used for catalyst quantification.  Instead, the 
carbene peak at 20ppm was used as evidence of the presence of active Grubbs’ catalyst.   
To test the temperature of 15-45 μm catalyst particles, wax or PS particles (0.15 g) were 
dispersed in a water (5 mL) and DETA (0.5 g).  The particles were stirred on low for 3 hours.  
The solution was then filtered and washed with water.  The particles were considered inactive if 
they could not be collected or if the gel time, measured by rheology, of the particles was greater 
than 1.5 hours.   
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CHAPTER 4 
MECHANICAL SMALL SIZE-SCALE SELF-HEALING IN EPOXY 
Parts of this chapter were previously published by the author:  
Jackson, A. C.; Bartelt, J. A.; Marczewski, K.; Sottos, N. R.; Braun, P. V. Silica-Protected 
Micron and Sub-Micron Capsules and Particles for Self-Healing at the Microscale. Macro. Rap. 
Comm. 2010, 31, 82-87. 
 
4.1 Motivation 
 The use of  small size-scale self-healing components in epoxy using a compartmentalized 
system is especially important in fiber reinforced composites where spacing between fibers limits 
the size of self-healing components that can be incorporated into the composite (Figure 4.1a).  
Previous work demonstrated the use of 1.5 μm capsules to heal fiber pull-out damage.[1]  Glass 
fibers are decorated with these capsules and with Grubbs’ catalyst (Figure 4.1b) and embedded in 
epoxy.  As demonstrated in fiber pull-out tests, this system recovers a significant portion of its 
fiber pull-out strength after damage and healing.  This chapter considers the next step, small size-
scale self-healing in the epoxy matrix using the DCPD/Grubbs’ catalyst chemistry.   
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Figure 4.1. (a) Reflection optical microscopy of a carbon fiber composite (adapted from [2]).  (b) 
SEM of glass fiber decorated with healing agents (adapted from [1]).   
 
 Small size-scale self-healing in bulk epoxy is not only important for limiting matrix 
damage between fibers but it is also important for understanding the limitations of mechanical 
self-healing for other applications requiring small size-scale self-healing.  Rule et al. studied 
these limitations for capsules as small as 15 μm in diameter.[3]  They found that maximum 
mechanical healing can only occur if the volume of the crack plane is equal to or less than the 
amount of healing agent supplied from capsules.  By geometry, the relationship between the 
capsule size, dc, and the mass of healing agent delivered, m, is linear as described by Equation 
4.1.  The healing agent delivered is also dependent on the density of the healing agent, ρ, and the 
fraction of capsules in epoxy, Ф.   
 
       Equation 4.1 
 
 Several challenges must be addressed to develop small size-scale self-healing in an epoxy 
matrix. Challenges with capsule dispersion in epoxy and catalyst encapsulation on the order of 1 
μm in diameter are partially addressed in Chapter 2 and Chapter 3.  This chapter further considers 
(a) (b) 5 μm10 μm
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how the DCPD-filled capsules and catalyst particles disperse in an epoxy matrix and retain 
activity.  The final challenge to developing small size-scale self-healing is the size of damage that 
can be healed.  DCPD-filled capsules as small as 30 μm in diameter effectively heal cracks as 
small as 3 μm.[3]  However, capsules 1 m in diameter are an order of magnitude smaller, so full 
healing is not expected unless damage is less than 300 nm wide.  Other self-healing systems with 
similar limitations for healing agent delivery show improved healing as compression is applied 
across the crack.[4, 5]  A similar strategy is applied here to decrease the damage volume.   
 
 
4.2 System Overview 
The epoxy matrix used in this work is based on the reaction of EPON 828 resin with 
diethylenetriamine (DETA) hardener.  A tapered double cantilever beam (TDCB) specimen is 
used to test the mechanical properties of the self-healing epoxy.[3, 6]  Due to the geometry of the 
TDCB (Figure 4.2a), crack propagation in the center portion of the TDCB is controlled and the 
crack toughness is independent of the crack length.  As a result, the healing efficiency (η), the 
ratio of healed fracture toughness (KIC, healed) to virgin fracture toughness (KIC, virgin), is also equal 
to the ratio of the healed peak load (Phealed) to the virgin peak load(PVirgin) as shown in Equation 
4.2.[6]   
 
  
         
          
 
       
       
 Equation 4.2 
 
For specimens with a center crack region of 50 mm, cracks propagate through the full 
sample and samples are manually placed together.  The resulting crack width is approximately 10 
μm based on work by Rule et al.[3]  These samples are referred to as long-grove TDCBs.  By 
decreasing the center region to 25mm long (Figure 4.2a), crack growth is arrested before full 
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damage to the sample occurs.  As a result, alignment is easier and the crack width is 
approximately 3 μm.  These samples are referred to as short-grove TDCBs.   
 
 
Figure 4.2. Short groove TDCB specimen.  (a) Dimensions in mm.  (b) Changes as compared to 
a standard short groove TDCB include: (1) a hole is drilled to arrest crack growth predictably; (2) 
healing agents are localized to the area surrounding the groove to minimize the quantity of 
healing agent used per sample; (3) force is applied during healing to artificially decrease the crack 
width.   
 
 For capsules larger than 15 μm, these specifications are sufficient for demonstrating 
healing.  However, several changes must be made to accommodate capsules and particles on the 
order of 1 μm in diameter (Figure 4.2b).  First, the quantity of capsules that can be produced does 
not fill a full TDCB sample.  As a result, micron size capsules and catalyst particles were 
localized minimizing the quantity of components that are needed for each test.  Second, cracking 
is inefficiently arrested in short grove TDCBs.  To reduce loss of valuable sample, a hole is 
drilled at the end of the crack region to effectively arrest crack growth.  Finally, as discussed 
previously, 3 μm wide cracks are theoretically too large to obtain effective healing.  To reduce the 
crack width, force was applied across the crack plane using clamps.  These clips apply a force of 
approximately 20-30 lb across the crack plane.  SEM imaging of clamped TDCBs held together 
with super glue suggest the applied pressure reduces the crack width along portions of the crack 
to 1 μm or smaller (Figure 4.3).   
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Figure 4.3. SEM of the edge of a crack in a TDCB specimen that has been cracked and mended 
with superglue while a force is applied across the crack plane using 20-30 lb of force.   
 
4.3 Dispersing Micron Size Components in Epoxy 
 The importance of a silica shell on DCPD-filled capsules and catalyst particles is 
apparent when comparing the dispersion of coated capsules to the dispersion of uncoated capsules 
in an epoxy matrix.  Uncoated capsules do not disperse well in epoxy at concentrations higher 
than 3 wt%.  A powder of coated capsules, coated using the fluoride-catalyzed method, disperses 
in epoxy at significantly higher concentrations than the uncoated capsules without any 
aggregates.  Figure 4.4 shows a comparison of uncoated capsules and coated capsules dispersed 
in epoxy at 10 wt%.  In all images, it is noted that all of the capsules rupture which is important 
for delivery of the healing agent.   
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Figure 4.4. SEM of a fracture surface of an EPON 828/DETA epoxy containing (a) uncoated and 
(b) coated capsules at 10 wt%.  Capsules are mixed into the uncured resin/hardener mixture as a 
dry powder. 
 
The incorporation of micron size capsules and catalyst particles into epoxy alters the 
polymer’s fracture toughness. Brown et al. showed previously [7] that capsules toughen epoxy 
through crack pinning, localized yielding and microcracking.  Blaiszik et al. [8] showed that 
small (1 μm or less in diameter) capsules further enhance toughening of the epoxy through both 
crack pinning and crack deflection mechanisms.  Crack deflection is evident in SEM analysis of 
the crack surface (Figure 4.4).  A slight increase in fracture toughness is observed at 7 wt% 
capsules but no increase is observed at 15wt% capsules (Table 4.1).  A dependence on capsule 
concentration is expected based on work by Brown et al.[7]   
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Sample Micron size catalyst 
particles 
1.5 μm DCPD 
capsules 
Fracture Toughness  
(MPa m
1/2
) 
Blank 0 wt.% 0 wt.% 0.86 +/- 0.02 
CGr 7 wt. % 0 wt.% 1.12 +/- 0.00 
CCap (7) 0 wt.% 7 wt.% 0.95 +/- 0.11 
CCap (15) 0 wt.% 15 wt.% 0.84 +/- 0.06 
CCap (15) + CGr  7  wt.% 15 wt.% 0.76 +/- 0.09 
 
Table 4.1. Fracture toughness of samples containing micron size catalyst and 1.5 μm DCPD 
capsules.   
 
 Similar results are observed for catalyst particles and samples containing both capsules 
and catalyst particles.  As discussed, only silica-coated catalyst particles protected by polystyrene 
(PS) and polymethylmethacrylate (PMMA) stay active in epoxy so only these are studied for 
epoxy applications.  These silica coated Grubbs’ catalyst particles disperse well in epoxy at high 
concentrations (Figure 4.5).  Although there is no visual evidence of particle cleavage, broken 
epoxy stubs do regain some mechanical properties when DCPD is injected into the damaged 
region suggesting that the catalyst is accessible.  Fracture toughening mechanisms, specifically 
crack deflection, is observed in the crack plane.  The fracture toughness of samples with 7wt% 
catalyst particles in epoxy is approximately 50% higher than samples without catalyst (Table 1).   
 
 
Figure 4.5. SEM of a fracture surface of an EPON 828/DETA epoxy containing 7 wt.% micron 
size catalyst particles.  Particles are mixed into the uncured resin/hardener mixture as a dry 
powder. 
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4.4 Activity of Grubbs’ Catalyst Particles in Epoxy 
While chapter 3 demonstrates the successful synthesis of catalyst particles, this section 
demonstrates successful polymerization of DCPD injected into the crack plane of short grove 
epoxy TDCBs.  TDCBs made with 2.5 wt% 45 μm in diameter PS particles containing 10 wt% 
Grubbs’ catalyst have an average healing efficiency of 25 +/- 5% based on mechanical data from 
3 samples (Figure 4.6).  No healing is observed for samples containing 45 μm in diameter PS 
particles without catalyst.  This healing efficiency is not quantitatively comparable to the healing 
efficiencies demonstrated in previous research due to differences in catalyst concentration and 
definition of healing efficiency.[9]  Qualitatively, a key difference between the PS-protected 
particles and wax-protected particles is the ductility of the healed material.  PS-protected catalyst 
particles make a more brittle healed material than the wax-protected catalyst particles.  This is 
likely a result of the wax plasticizing the polyDCPD.  The brittle nature of the healed material 
created by PS-protected particles is similar to the healed material made by unprotected catalyst.   
 
 
Figure 4.6. Virgin (dotted line) and healed (solid line) load displacement curves for epoxy short-
grove TDCBs containing 45 μm Grubbs’ catalyst particles.  5 μL DCPD is injected into the crack 
plane.   
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Micron size Grubbs’ catalyst particles also provide sufficient catalyst to the crack plane 
to polymerize DCPD injected into the crack plane.  As discussed in chapter 3, only silica-coated 
catalyst particles protected by PS and polymethylmethacrylate (PMMA) in the core remain active 
in epoxy.  The healed peak load is approximately 20 N and the healed polymer is brittle in nature, 
similar to the nature of the healed polymer created by the 45 μm PS-protected catalyst particles.  
In controls, it is shown that at least a part of this healing is the result of a solvent welding 
mechanism where the PS from the catalyst particles dissolves and redeposits in the crack plane.  
Samples containing particles without catalyst have a healed peak load of approximately 7 N.  The 
healed surface shows a polymer film in both cases (Figure 4.7).  Unlike the 45 μm PS particles, 
samples with micron size particles have a higher surface roughness in the crack plane.  It is likely 
that the higher surface area allows some mechanical interlocking between the matrix and healed 
polymer.   
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Figure 4.7. Samples containing catalyst particles (7 % w/w, CGr), polymer particles (7 % w/w) 
or no self-healing agents were injected with DCPD and clamped after virgin fracture.  (a) Healing 
efficiency.   SEM images of a portion of the crack surface where healing occurred is shown for 
samples containing (b) catalyst particles and (c) polymer particles. 
 
4.5 Small Size-scale Self-healing in an Epoxy Matrix 
  TDCBs containing micron size capsules and catalyst particles retain approximately 20% 
of their original fracture toughness.  The average healed peak load for this system is 15.0 N 
(Figure 4.8a).  The load displacement curve shows brittle fracture of the healed material (Figure 
4.8b).  The fracture surface of the healed sample has a thin film across a fraction of the crack 
surface (Figure 4.8d).   Samples containing catalyst alone or capsules alone show no healing.  
However, samples containing DCPD capsules and composite polymer particles without catalyst 
show healing similar to the samples with injected DCPD.  As mentioned, this is attributed to 
capabilities of DCPD to dissolve the PS and redeposit it in the crack plane.   
0
0.1
0.2
0.3
CGr,inj Cpoly,inj blank
DCPD injected
H
e
al
in
g 
Ef
fi
ci
en
y
(%
)
BlankCGr CPoly
(a)
20 μm(b)
20 μm(c)
30
20
0
0
74 
 
 
 
Figure 4.8. (a) Healing efficiency for short groove TDCB specimens containing capsules and 
catalyst particles (15 % w/w CCap; 7 % w/w, CGr), capsules and polymer (catalyst free) particles 
(15 % w/w CCap; 7 % w/w CPoly), or only capsules (15 % w/w, CCap),  (b) Typical load 
displacement curve of a full sample (CCap + CGr) with both the virgin (dashed line) and healed 
(solid line) fracture.  SEM of the crack surface of a sample containing capsules and catalyst 
particles (c) before and (d) after healing.  A polymerized polyDCPD film can be seen on the crack 
surface.   
 
 
4.6 Conclusions  
 Small size-scale self-healing in an epoxy matrix is demonstrated with DCPD-filled 
capsules and PS-protected catalyst particles on the order of 1 m in diameter.  Both components 
disperse well in epoxy at high concentrations and toughen epoxy through crack pinning and crack 
deflection.  PS-protected catalyst particles, both 45 μm and sub-micron in diameter, successfully 
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catalyze the polymerization of DCPD injected into the crack plane.  This confirms that the PS-
protection scheme and manufacture process do not lead to significant catalyst deactivation.  A 
portion of the healing observed when using sub-micron catalyst particles is a result of PS from the 
catalyst particles redepositing in the crack plane.  TDCBs containing 15 wt.% DCPD-filled 
capsules and 7 wt.% catalyst particles recover a portion of the epoxy’s initial properties.  To 
accomplish this, force is applied across the crack plane to reduce the damage volume.  An 
average healing efficiency of 20% is observed in the full system.   
 
4.7 Experimental 
4.7.1 Materials 
Dicyclopentadiene (DCPD) was purchased from Alfa Aesar (90+%, stab. with 150-
200ppm p-tert-butyl catechol).  The DCPD was distilled to remove cyclopentadiene and any 
oligomeric units that might be present.  Grubbs‘ catalyst and wax (mp=58-62 °C) were purchased 
from Aldrich.  Grubbs‘ catalyst was kept in a nitrogen glovebox until use.  Ammonium chloride 
(NH4Cl) and urea were purchased from Sigma-Aldrich.  Formaldehyde solution (37wt% 
formaldehyde in water) was purchased from Fisher Chemicals.  Ethylene maleic anhydride 
copolymer was donated by Zeeland chemicals (EMA, MW=400000).  This was used as a 2.5 % 
w/w solution in water.  Polystyrene (PS, MW=280000), polymethylmethacrylate (PMMA, 
MW=120000), cetyltrimethylammonium bromide (CTAB), tetraethylorthosilicate (TEOS), and 
tetrabutylammonium fluoride (TBAF, 75wt% in water) were purchased from Sigma.  TBAF was 
diluted to 0.75wt% for use.  EPON 828 was purchased from Miller Stephenson and 
diethylaminetriamine (DETA) was received from Dow Chemical. 
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4.7.2 Self-healing Composites 
DCPD capsules and Grubbs catalyst particles are synthesized according to the procedures 
described in Chapter 2 and Chapter 3.  All micron size DCPD capsules were coated using the 
fluoride-catalyzed silica condensation chemistry.  All sub-micron catalyst particles are made 
using the composite particle method.  PS and polymethylmethacrylate (PMMA) protect the 
catalyst in the particle core while a silica shell is added using the fluoride-catalyzed silica 
condensation chemistry.  45 μm catalyst particles are only protected with PS using the emulsion 
solvent evaporation procedure with quench bath.   
All self-healing samples were prepared by mixing EPON 828 and diethylenetriamine 
(DETA) at 12wt.% DETA in EPON 828.  Vacuum was applied to the resin/hardener mixture for 
10 minutes before adding the encapsulated healing agents.  After the encapsulated healing agents 
were added, vacuum was reapplied for 5 minutes.  The final mixture was poured into the 
appropriate mold and cured for 24 hours at room temperature followed by 24 hours at 35 °C.   
Short-groove tapered double cantilever beam (TDCB) specimens were prepared as 
described previously [3] but with the changes described in Figure 2.  After virgin fracture, 
Pressure was applied to the sample using spring-loaded clamps to minimize the crack width.  The 
sample was then allowed to heal for 24 hours and retested.  For injected healing tests, DCPD (5 
μL) was injected into the crack plane before applying pressure to the sample. At least 3 samples 
were tested for each data point.  Fracture toughness was calculated based on work by Brown et 
al.[6, 7] 
The morphologioes of fracture planes were analyzed using SEM (Philips XL30 ESEM-
FEG).  To determine the width of the TDCB cracks while under pressure, superglue was added to 
the crack plane after virgin fracture.  The samples were clamped and the superglue was dried for 
24 hours.  The crack width was estimated by analyzing at the edge of the crack plane using SEM.   
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CHAPTER 5 
OPTICAL SELF-HEALING IN POLYMETHYLMETHACRYLATE 
Parts of this chapter are submitted for publication to Advanced Functional Materials 
 
5.1 Motivation 
This chapter focuses on self-healing polymethylmethacrylate (PMMA) for optical 
applications but the concepts developed can be applied to other thermoplastic systems.  PMMA is 
an important material used in optical materials [1, 2] and biomaterials.[3]  Relevant optical 
applications include Fresnel lenses, lens coatings and protective coatings for artwork.  Fresnel 
lenses made of PMMA are, for example, important in concentrating photovoltaic modules.[2]  
Microcracking often occurs as a result of the build-up of residual stresses during manufacture.  
The micro-cracks grow further when exposed to adverse environmental conditions, such as 
temperature cycling and humidity.[1, 2]  The cracks can result in hazing and compromise the 
mechanical stability of the Fresnel lens.  Similar damage in lens coatings and artwork coatings 
result in significant light scatter and environmental damage to the underlying substrate.   
This research addresses these issues by autonomically healing the microcracking.  This 
both reduces light scatter from microcracks and maintains the protective capabilities of the 
polymeric coating while retaining a portion of the mechanical properties in the coating.  Along 
with utilization of a chemical system appropriate for healing a thermoplastic, the two primary 
challenges towards developing an optically transparent self-healing system are: (1) minimization 
of light scatter from capsules in the polymer matrix and (2) minimization of light scatter from the 
healed material in a polymer matrix.  To develop a self-healing optical system containing 
capsules, index matching to minimize reflections or light scatter from interfaces between phases 
with differing refractive indices is necessary.  Here we demonstrate a new self-healing chemistry 
that enables index matching of the matrix, the capsules, and the healed material, largely 
eliminating light scatter. 
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A thermoplastic solvent welding chemistry allows a relatively simple index matching 
scheme.  In solvent welding, the polymer matrix swells in a solvent and deposits part of the 
matrix in the damaged area, fixing small defects in thermoplastic polymer.[4]  For self-healing, 
the solvent simply needs to be encapsulated and appropriately dispersed in the thermoplastic 
matrix.  As a crack propagates through the matrix, capsules are broken, and the solvent wicks into 
the crack plane initiating the solvent welding mechanism (Figure 5.1).  Careful choice of the 
solvent and matrix can reduce light scatter from the capsules through index matching.  If properly 
designed, the healed material can be designed to be inherently index matched to the polymer 
matrix, minimizing light scatter from the healed region. 
 
 
 
Figure 5.1. Schematic of the solvent welding mechanism in a polymer matrix.  During a damage 
event, capsules rupture (a), releasing all or most of their contents (light gray) into the crack plane 
(b).  Over time, the solvent in the crack plane diffuses into the polymer and the polymer swells 
and flows into the crack plane leaving a plasticized polymer (dark gray) in the healed region (c).  
Eventually the solvent disperses into the polymer, leaving behind essentially intrinsic material in 
the crack plane (not shown).  
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5.2 System Overview 
The particular thermoplastic matrix studied in this work is PMMA.  Prior work in solvent 
welding of PMMA used methanol (n=1.33) and ethanol (n=1.36),[4, 5] but these solvents are not 
readily encapsulated and are poorly index matched to PMMA (n=1.49).  Useful solvents for 
solvent welding PMMA with refractive indices similar to PMMA include ethylphenyl acetate 
(EPA, n=1.50), and dibutyl phthalate (DBP, n=1.49).  Although a research has been performed 
using DCPD filled capsules,[6-8] DCPD does not readily swell PMMA.  Previous work has also 
demonstrated encapsulation of EPA for solvent welding.[9, 10]  However, we chose DBP as a 
self-healing agent since it is more closely index matched to PMMA and has a larger molecular 
size, decreasing its permeability through the shell wall, resulting in capsules with better stability.  
Although DBP is left behind after healing due to its low volatility, its plasticization properties can 
plasticize the surrounding PMMA, increasing toughness in the healed region. 
Control of the characteristic length scales of the healing agent is important as it can be 
used as a tool to minimize light scatter.  Here, two sizes of capsules are considered: 1.4 μm and 
~75 μm diameter capsules.  For comparison to previous sonicated capsules, Figure 5.2 shows the 
size distribution of 1.4 μm DBP capsules.  In all cases, the capsule diameter must be less than the 
film thickness or a rough, highly scattering film will result.  In optical lenses for example, 
coatings as thin as 10 μm are common, and thus only small capsules could be used.  One 
advantage of using thinner films and smaller capsules is the reduced scatter and path length for 
light through the material.  A difficulty in using smaller capsules, however, is the decreased 
quantity of healing agent supplied to the damaged region.  Previous work demonstrated that, as 
the capsule size decreases, the amount of healing agent released into the crack plane decreases 
with a linear dependence on the capsule diameter,[11] limiting the size of cracks that can be 
healed by small capsules. 
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Figure 5.2 (a) SEM of DBP capsules and (b) size distribution of 1.4 μm DBP capsules as 
measured from SEM images.   
 
Successful thermoplastic solvent-based self-healing requires a good understanding of 
capsule stability during their manufacture, the nature of the interface between the capsules and 
polymer matrix, and the upper bound to the extent of healing that can occur.  As shown 
previously, solvent capsules have poor stability when extruded with a thermoplastic polymer as a 
result of the high temperatures and pressures required for processing.[10]  Solvent casting 
minimizes shear, but the solvent used and the conditions required to remove the solvent must not 
damage the capsules.  The capsules must survive both elevated temperatures and exposure to 
solvents at those temperatures with little or no loss of healing agent.  This is demonstrated in 
Chapter 2 where both 75 μm capsules and 1.4 μm capsules lose none of their contents after 1 hour 
at 90 °C in anisole.   
The interface between a capsule and its polymer matrix is important for capsule 
dispersion and capsule rupture during damage.  For example, as discussed in chapter 4, silica 
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coated DCPD capsules disperse better than unmodified DCPD capsules in epoxy.  For self-
healing optically transparent materials, the capsules must be well dispersed in the polymer, and 
must be fractured by a damage event, both of which require a well engineered capsule-matrix 
interface.  Both small and large capsules require interface engineering.  As shown in Figure 5.3a, 
unfunctionalized, silica coated 1.4 μm diameter capsules aggregate during the spin coating 
procedure used to form PMMA coatings while methacryl functionalized silica-coated capsules 
disperse well (Figure 5.3b).  Uncoated, 75 μm capsules also require interface engineering.  When 
the composite coating is cracked, uncoated capsules pull out of the PMMA matrix instead of 
rupturing to release their contents (Figure 5.3c).  Neither a silica coating nor methacryl 
functionalization provides obvious improvements for capsule rupture (unlike the case for the 
smaller capsules).  Once the larger capsules are soaked in a solution of anisole and PMMA, or 
annealed in the dry state at 140 °C before dispersing them in PMMA, improved capsule rupture is 
observed.  Figure 5.3d shows a representative image of successful capsule rupture in a PMMA 
matrix.  It is important to note that 1.4 μm DBP capsules consistently rupture when damaged as 
observed by SEM (Figure 5.3e).   
 
 
 
 
83 
 
 
Figure 5.3. Transmission optical microscopy of capsules in PMMA: small coated capsules 
without functionalization (a); small coated capsules with  methacryl functionalization (b); large 
uncoated, unmodified, capsules that do not ruptureas a result of crack damage (c) and large 
uncoated capsules, annealed prior to incorporation in PMMA, that do rupture as a result of crack 
damage (d).  An SEM of a crack surface of PMMA containing 1.4 μm capsules (e).  Arrows in (c) 
and (d) point to the crack damage in each sample.   
 
5.3 Optical Properties of Capsule-containing Films 
MIE scattering calculations for small, 1.4 μm, capsules enable determination of the effect 
of refractive index on light scatter from capsules and transmission through coatings containing 
the capsules.  The calculations are based on Matlab code written by Bond et al. to calculate light 
scatter of particulate matter in an atmosphere.[12]  Three refractive indices are important: that of 
the matrix (nm), the capsule core (nc) and the capsule shell (ns).  As the refractive index difference 
between the capsule core and matrix increases (Δn), the calculated transmission decreases.  For a 
system containing 5 wt.% capsules, below Δn ~ 0.02, the calculated transmission is greater than 
90% of the sample without capsules.  EPA and DBP both have a refractive index within 0.01 of 
PMMA.  As the refractive index of the capsule shell is varied, the calculated transmission is 
affected, but not by more than 5% for Δn = 0.06 (Figure 5.4).  This is expected since the shell 
wall makes up only a small volume fraction of the final composite.  The shell’s thickness, only 70 
nm, additionally reduces its scattering strength.  Previous work [13] demonstrates that optical 
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composites with inclusions smaller than the wavelength of light can tolerate a larger mismatch in 
refractive index between the two phases than composites with inclusions larger than wavelength 
of light. 
 
 
Figure 5.4: Theoretical calculation of transmission for various indices of refraction for the core 
material and shell material of micron size capsules.  Here, the matrix index of refraction is taken 
as 1.489, the capsule diameter is 1.4 μm, the shell thickness is 50 nm, the wavelength is 550 nm 
and the capsules are dispersed at 5 wt.% in a 10 μm thick film.   
 
Capsules deposited on a glass slide demonstrate how index matching the core material to 
the polymer matrix can reduce light scatter in the sample.  For a submonolayer of capsules 
(surface coverage of ~35%), due to the index mismatch between air and the capsules, light 
scatters such that features beneath the sample are cloudy (Figure 5.5).  For the same 
concentration of capsules in a PMMA coating, light scatter is nearly eliminated due to index 
matching and features beneath the sample can be seen (Figure 5.5b).  Optical microscopy and 
UV-vis spectroscopy confirms that the light scatter from the capsules is minimal due to index 
matching (Figure 5.5c,d,e). 
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Figure 5.5. 1.4 μm uncoated capsules containing DBP (a) deposited on a glass slide and (b) after 
a 10 μm thick PMMA film is spun coat onto the same sample.  Transmission optical microscopy 
images of the capsules (c) before and (d) after PMMA addition.  (e) UV-vis of the glass slide (1, 
dashed), the glass slide with deposited capsules (2), and the glass slide with capsules in PMMA 
(3). 
 
 
As expected, 75 μm capsules scatter more light than 1.4 μm capsules.  When the large 
DBP capsules are dispersed in PMMA, light scatter is observed but the composite is relatively 
clear with a light transmission above 70% in the visible spectrum (Figure 5.6).  In comparison, 
DBP capsules dispersed in polystyrene, which has poor index matching, scatter more light and 
light transmission is less than 50% throughout the visible spectrum.  Much of the light scatter in 
the PMMA films is a result of PUF particles that could not be removed during the capsule work-
up (Figure 5.6c).  This scatter is still acceptable for applications that do not require high quality 
optics.   
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Figure 5.6. 6 wt.% 75 μm DBP capsules dispersed in (a) PMMA and (b) PS.  Transmission 
optical microscopy of  the capsules in (c) PMMA and (d) PS.  UV-vis of the capsules in (e) 
PMMA and (f) PS.  Acrylic substrates (gray lines) and acrylic substrates with respective polmyer 
films (dotted lines) are shown for comparison.   
 
5.4 Optical and Barrier Properties of the Healed Polymer 
The focus here is on sub-micron damage created by brittle cracking as a result of 
mechanical stresses.  Healing occurs only when the crack is wet by healing agent.  15wt.% of the 
1.4 μm diameter capsules are capable of delivering sufficient DBP to fill cracks up to 200 nm 
wide.  75 μm capsules contain enough healing agent at 5 wt.% in PMMA to fill cracks up to 7.5 
μm wide.  The final films are designed to be 100 μm thick for small capsules and 170 μm thick 
for large capsules.  They are drop cast on acrylic and, based on SEM analysis, the actual thickness 
in the center of the samples (1.27 cm by 2.54 cm) varies by plus or minus 50 μm from the 
predicted values.  The thickness tapers to 0 μm over a 200-500 μm wide area on the edge of the 
sample.  Bending these films on acrylic substrates produces cracks narrower than 50 nm at the 
surface as observed by AFM and SEM and as large as 1 μm below the surface as observed by 
SEM (Figure 5.7).  Some of the damage is a result of buckling as the edges of the crack come 
back together due to the restoring force from the acrylic substrate.  Despite being smaller than the 
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wavelength of light, these cracks are optically visible (Figure 5.8a). Optical imaging also 
suggests that damage below the surface is more extensive but the extent of damage could not be 
determined quantitatively.   
 
  
Figure 5.7. (a) AFM and (b) SEM of the top view of cracking in PMMA without capsules.  (c) 
SEM of cracking extending below the surface.  Arrows point to the crack observed in (b) and (c).   
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Figure 5.8. Transmission optical microscopy (TOM) and reflection optical microscopy (ROM) of 
cracks or healed cracks in (a) PMMA, (b) PMMA with 10 wt.% small capsules, and (c) PMMA 
with 6% large capsules. Arrows point to cracks or healed cracks in the samples.   
 
An electrochemical setup, similar to the setup used by Cho et al. (Figure 5.9),[14] 
highlights regions where cracks are deep enough to provide a path between the surrounding 
environment and the substrate.   Silver paste, coated onto the acrylic substrate, is the conductive 
substrate for these samples since the samples retain the mechanical properties of the acrylic 
substrate resulting in crack structure similar to samples without the silver paste.  As a result, no 
substrate damage occurs during these tests due to the inertness of the silver.  In cracked samples, 
a current is observed as a voltage is applied across the coating and solution since a conductive 
path exists between the electrode and the substrate (Figure 5.9b).  For non-damaged or healed 
samples, no current is observed since the electrolyte solution does not come into contact with the 
substrate.   
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Figure 5.9. (a) the electrochemcial setup.  (b) Current observed as voltage is applied across a 
virgin or healed substrate (black line) and a damaged substrate (gray line).   
 
Small capsules, 1.4 μm in diameter, provide partial healing in PMMA.  During initial 
damage, the sample is bent until the crack(s) initiated propagates across the width of the sample.  
Immediately after damage, portions of the crack fill in with DBP and are no longer visible by eye.  
After 24 hours, the healed regions remain invisible (Figure 5.8b) and electrochemical 
measurements in those areas demonstrate that the protective capabilities of the film are retained.  
Unhealed regions also exist and can be seen visually and probed electrochemically.  Optical 
microscopy demonstrates that capsules rupture along the crack plane and leave behind empty 
voids as healing agent wicks into the crack plane (Figure 5.8b).  The emptied capsules scatter less 
light than the initial crack, and do not affect optical healing at a macroscopic level.  By measuring 
the total length of healed cracks and dividing by the total length of the crack, the healed fraction 
is found.  For samples containing 3 wt.% small capsules in PMMA, approximately 30% of a 
crack is healed while for samples containing 15 wt.% capsules, approximately 40% is healed.   
Large capsules, 75 μm in diameter, provide more healing agent to the crack plane and, as 
a result, can achieve full healing at low concentrations at the expense of increased light scatter.  
As discussed, annealing the capsules prior to dispersion in PMMA maximizes capsule rupture and 
healing efficiency.  Below 6 wt.%, the annealed large capsules provide only partial healing 
similar to healing demonstrated for small capsules.  At concentrations above 6 wt.%, large 
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capsules provide enough healing agent for full healing as observed both visually (Figure 5.8c) 
and electrochemically.  The healing process starts quickly and can be seen as soon as healing 
agent is released into the crack plane.  Especially at higher capsule concentrations, so much 
healing agent is released that pools of DBP form on the sample surface.  Video of healing is 
available in the supplementary information.  At all concentrations, the fraction of crack that is 
healed for the annealed capsules is higher than the fraction of crack that is healed for capsules not 
annealed (Figure 5.10). 
 
 
Figure 5.10. Fraction of crack healed for PMMA coatings containing 75 μm DBP filled uncoated 
capsules (1) and uncoated capsules annealed at 140 °C (2).  Averages taken over at least 4 
samples.  Error bars are the standard deviation.  For 8 wt.% annealed capsules, 100% healing was 
observed in all sample thus no error bar is shown. 
 
5.5 Rate and Extent of Thermoplastic Self-healing 
The time scale for healing and extent of healing are important for developing a better 
understanding of thermoplastic self-healing and optimizing the self-healing response.  Although 
PMMA particles, as received from Sigma, remain unswollen after 72 hours in DBP, imaging of 
cracked regions in self-healing samples after 72 hours suggest that diffusion of DBP into the 
PMMA matrix does occur.  In samples healed for 1 minute, the original cracks open across the 
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length of the crack beginning at low bending strains, indicating healing has not occurred.  These 
cracks grow in width as more strain is applied.  Liquid healing agent that remains in the crack 
plane reduces light scatter from the crack when open and remains in the crack plane after the 
bending strain is removed, resulting in recovery of the initial optical properties of the healed 
polymer (Figure 5.11a).  After 72 hours, the original cracks are not observed until a sufficient 
bending strain is applied to recrack the cracks.  Cracks typically re-initiate from defects in the 
healed region, especially emptied capsules (Figure 5.11b).  The cracks remain visible after the 
bending strain is released suggesting that DBP had first promoted chain entanglement in the crack 
plane and subsequently diffused far into the PMMA after 72 hours. 
 
 
Figure 5.11. (a) Reflection optical microscopy images of PMMA films containing 6 wt.% DBP 
capsules after healing for 1 min followed by bending.  (b) Samples are then allowed to heal for 72 
hours before re-testing.  Scale bars are 200 μm; arrows point to locations of healed cracks. 
 
The healing capabilities of a single capsule demonstrate the extent of healing that can 
occur in this system.  In damaged samples, a single large capsule can heal a crack as long as 1 
cm.  This is approximately half of the healing expected from volume calculations: assuming a 
50nm wide crack in a 200 μm thick coating, and 75 μm capsules, a single capsule should heal as 
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much as 2 cm.  A number of factors reduce the actual healing.  First, healing agent exits the top of 
the crack plane and forms pools on the sample surface.  In addition, capsules often release only a 
portion of their contents (Figure 5.8c) perhaps due to the thinness of the cracks being tested.  
Finally, the crack may be wider than 50nm in some regions. 
 
 
 
5.6 Conclusions 
 A solvent welding self-healing system is developed for the optical thermoplastic polymer 
PMMA.  By employing index matching between the healing agent and polymer matrix, thin films 
of PMMA containing DBP capsules transmit sufficient light to be useful for optical applications.  
Two capsule sizes are studied: small, 1.4 μm, capsules are important for thin film applications in 
which larger capsules will not fit; and large, 75 μm, capsules are important for applications where 
more healing agent is required.  In both cases, the capsules retain most of their contents during 
work-up, are well dispersed and rupture well during a crack event.  Partial healing occurs for 50 
nm cracks in PMMA containing either size capsule.  Because the healed material is inherently 
index matched to the polymer matrix, light scatter from the damaged area is minimized allowing 
recovery of the optical properties of the polymer film after cracking.  The protective capability in 
the healed areas is also regained as demonstrated by potentiostat measurements.  Full healing of 
the crack occurs in PMMA samples with more than 6 wt.% large capsules.  After 72 hours, 
polymer diffusion occurs in the crack plane and mechanical healing is observed.  Finally, healing 
in thin films is only limited by the thickness of the film.  The healing capabilities of a single 
capsules is approximately half of what is expected based on geometry calculations.  The 
remaining healing agent pools on the surface of the film.   
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5.7 Experimental 
5.7.1 Materials 
Ammonium chloride was purchased from Sigma.  Monobasic sodium phosphate and 
sodium chloride were purchased from Fisher Scientific.  Brij 97, Resorcinol, urea, 
dibutylphthalate (DBP), ethyl phenyl acetate (EPA), formaldehyde solution, tetrabutyl 
ammonium fluoride (TBAF), and tetraethylorthosilicate (TEOS) were purchased from Sigma-
Aldrich.  Formaldehyde was purchased as a 37.5 wt.% solution and TBAF was purchased as a 75 
wt.% solution in water.  For all experiments, 1 mL TBAF was diluted with 100 mL Millipore 
water.  Ethylene maleic anhydride (EMA) surfactant was donated by Vertellus (chemical name 
ZeMac).  For all experiments, a 2.5 wt.% solution of EMA in water was made and used.  
Polymethylmethacrylate (PMMA, 35000 g/mol), methyltriethoxy silane (MTMS), 
cetyltrimethylammonium bromide (CTAB), and anisole were purchased from Acros.  
Methacryloxypropyltrimethoxy silane (MPTMS) was purchased from Gelest.  Cast acrylic (0.06” 
thick) was purchased from McMaster Carr.  Silver paste was purchased from Ted Pella.   
 
5.7.2 Fabrication of Self-healing Coatings 
 1.4 μm capsules and 75 μm capsules were both synthesized based on the procedures 
outlined in chapter 2.  1.4 μm capsules contained DBP and were coated using the fluoride-
catalyzed silica condensation chemistry.   
Self-healing coatings were fabricated via one of two solvent casting methods.  Self-
healing coatings less than 10μm thick were prepared via spin coating.  A solution of 30 wt.% 
PMMA in anisole was first prepared.  Next, 1.4 μm, uncoated capsules were deposited on a 1 mm 
thick glass slide using a method similar to convective assembly of colloid crystals described 
elsewhere.[15] The solution was then spun coat at 3000 rpm for 30 seconds and dried in an oven 
at 90 °C for 12 hours.  Two layers of PMMA without capsules were spun coat as a capping layer 
to assure that no capsules penetrated the surface of the samples.   
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Self-healing coatings 100-500 μm thick were prepared via drop casting.  A solution of 20 
wt.% PMMA in anisole was prepared and the desired fraction of capsules added.  Vacuum was 
pulled on the mixture to remove any trapped gas.  The solution was dropped onto a 1” x 0.5” x 
0.06” acrylic substrate in a quantity corresponding to the anticipated thickness based on volume 
calculations.  For small capsules, 0.15 mL of the solution containing capsules and polymer was 
dropped onto the substrate while 0.25 mL of solution was used for large capsules.  The sample 
was dried in an oven at 140 °C for 15 hours forming a polymer film.   
0.06” thick acrylic substrates were used for all samples analyzed using transmission 
optical microscopy.  For reflection optical microscopy and electrochemical experiments, a 
reflective substrate was required.  To achieve this while maintaining similar cracking properties 
to the acrylic substrate, silver paint was applied to one side of an acrylic substrate and dried for 1 
hour at 140 °C before the solvent casting step.   
Large capsules required one of two methods to ensure efficient rupture in PMMA.  In the 
first method, capsules were heated in the dry state to 140 °C for 15 minutes before being 
incorporated into the PMMA solution described above.  In the second method, capsules were 
soaked in the PMMA solution for 1 hour before drop casting.   
 
5.7.3 Analysis of Self-healing Coatings 
Simulations of transmission were done using Matlab code developed by Bond et al.[12]  
Small capsules are modeled with a 1.4 μm diameter core and 70 nm shell.  To calculate 
transmission, the PMMA sample is modeled as a 10 μm thick film containing 5 wt.% capsules.  
All UV-vis measurements were done with air as background in a UV-vis spectrometer (Shimadzu 
UV-2450 Spectrophotometer). 
To induce damage in the PMMA films, samples were bent in a 3-point bend 
configuration.  Sufficient force was applied to cause cracking across the full sample.  Unhealed 
damage was analyzed in AC mode on an Asylum Cypher AFM in air using oxide-sharpened 
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silicon probes having a resonance frequency in the range of 280–320 kHz (MikroMasch–NSC15).  
The cross-section of the crack was prepared by first cracking through the PMMA film in one 
direction followed by cracking through the PMMA and substrate in the perpendicular.  Unhealed 
and Healed damage was analyzed by optical microscopy and electrochemical measurements.   
An electrochemical setup similar to previous research [14] was used to demonstrate the 
protective capabilities of the self-healing coating.  An image of the setup is included in the 
supplementary information.  Briefly, substrates of acrylic coated with silver paste were used in 
the drop casting step.  The silver layer was connected to a reference electrode while a working 
electrode was brought into contact with a drop of electrolyte solution on the sample surface.  To 
assure that the electrolyte solution had wicked into the crack plane, the sample was flexed to 
temporarily widen visible cracks without re-damaging any healed regions.  The electrolyte 
solution consisted of 1M NaCl and 1 wt.% Brij 97.  1 V was applied across the electrodes and the 
current recorded over 60 seconds.   
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CHAPTER 6: 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
6.1 Conclusions 
 Small size-scale self-healing systems for composites and optical materials are 
successfully developed and analyzed.  In particular, liquid-filled capsules and active particles on 
the order of 1 m in diameter are synthesized and modified such that that minimal aggregation 
and loss of healing agent occurs during processing.  Silica condensation onto 1.4 m capsules is 
particularly effective at improving capsule dispersion in both epoxy and polymethylmethacrylate 
(PMMA).  The coatings do not significantly improve capsule stability, however during this work 
it was found that capsule stability can be significantly enhanced through appropriate work-up 
conditions.  Catalyst is successfully protected by polymer and silica in sub-micron particles.  The 
silica coating is important for making reducing catalyst deactivation when the particles are cured 
in epoxy.  These capsules and particles are implemented in an epoxy system where the size of 
damage must be less than 1 m wide for effective healing to occur.  Similarly, partial healing can 
occur in thermoplastic materials containing micron size dibutyl-phthalate (DBP) capsules.  
Silica-coated capsules are coated using three different methods: Stöber condensation, 
fluoride-catalyzed silica condensation, and fluidized bed reactor chemical vapor deposition (FBR-
CVD).  Stöber chemistries are well understood and have been shown to build dense silica shells 
on a variety of surfaces but the alcohol solvents required for the chemistry limit its use.  Capsules 
larger than 20 m cannot be coated using this method because the alcohols weaken the shell wall 
resulting in capsule bursting under mild stirring conditions.  1.5 m diameter DCPD filled 
capsules formed via sonication assisted synthesis can be coated in an alcohol solution as long as 
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the alcohol solution is first saturated with DCPD.  This requirement limits the Stöber chemistry to 
capsules containing solvents that can form saturated solutions in alcohols.  FBR-CVD does not 
require solution conditions and is capable of coating a variety of surfaces with functionalities not 
amenable to solution processing techniques.  This method, however, requires that the interactions 
between capsules be less than the shear forces available in the FBR.  Fluoride-catalyzed 
chemistries are the most promising route to a generalized silica condensation method for 
capsules.  Although the surface chemistry of the capsules is important, polyureaformaldehyde 
capsules at all size scales are successfully coated using this method by controlling the solution 
ionic environment.  For 1.5 μm capsules, the silica coating is necessary as the coated capsules can 
be dried to a dry powder for incorporation into a polymer matrix.  This is not possible with 
uncoated capsules.   
 Although the silica coating process adds an extra diffusion barrier to the capsules, no 
significant changes in capsule stability are observed.  Instead, in depth studies of capsule stability 
demonstrate other important parameters for minimizing content loss in a variety of conditions.  
The capsule work-up conditions have the greatest impact on thermal stability.  In particular, 
ethanol-rinsed PUF capsules perform significantly better than water-rinsed capsules.  It is 
expected that this is a result of the ethanol washing out trapped solvent molecules in the capsule 
wall and this results in pore closure as the ethanol evaporates.  The molecule size also plays an 
important role as capsules containing DBP have a consistently smaller diffusion coefficient in 
PUF than capsules containing DCPD or EPA.  Of particular interest is that DCPD capsules have a 
consistently lower diffusion coefficient in PUF than EPA despite having a smaller molecular 
weight and higher volatility at 20 °C.  This demonstrates the importance of the interactions 
between solvent molecules and the PUF shell on stability.  Solvent stability is also a key 
component for understanding capsule stability and is important for applications requiring solvent 
casting processing.  Although quantitative data could not be collected, qualitatively, the size of 
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the solvent molecule also plays an important role on healing agent loss in a good solvent.  In fact, 
while EPA capsules tend to lose a portion of their contents in anisole at 80 °C, no loss is observed 
from DBP capsules under the same conditions.   
 Grubbs’ catalyst particles are also subject to healing agent loss under adverse conditions 
and polymer encapsulation plays an important role in minimizing loss.  While wax has been used 
previously to protect the catalyst particles, the size of the particles cannot be reduced to match the 
size scale of the 1.5 m DCPD capsules coated in Chapter 2 due to aggregation.  In addition, the 
wax particles break down above 35 °C and dissolve in epoxy during a cure cycle at 50 °C.  
Polystyrene (PS), on the other hand, can be made into sub-micron particles using an emulsion 
solvent evaporation procedure and these particles remain well dispersed after drying.  On the 
micron size-scale, PS is insufficient to protect the catalyst in epoxy so polymethylmethacrylate 
(PMMA) and silica are used with the PS to build stable particles.  At larger sizes, above 15 m, 
PS is sufficient to protect the catalyst and the particles can survive intact in air up to 65 °C.  
Unlike the wax particles, they also remain intact while curing epoxy, containing the particles, at 
50 °C.   
 The 1.5 m coated DCPD capsules and sub-micron catalyst particles are effective at 
healing damage events on the order of 100 nm in epoxy using a short-grove tapered double 
cantilever beam (TDCB) specimen.  Both components disperse well and remain active during the 
epoxy curing procedure.  A pressure applied across the crack plan reduces the crack width in 
regions of the TDCB to as small as 100 nm simulating the smaller damage events that can be 
healed with the limited healing agent available in the 1.5 m capsules.  Healing in the full system 
approaches 22%.  Part of this healing is a result of PS redistribution in the crack plane and 
mechanical interlocking with the crack plane.   
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 Coated liquid capsules also open new possibilities for self-healing in transparent 
thermoplastic polymers.  In particular, DBP filled coated capsules, both 1.5 m and 80 m, are 
used to heal PMMA while maintaining a good transparency in the polymer.  1.5 μm capsules 
require a silica shell to remain dispersed during the solvent casting steps for building a PMMA 
film.  1.5 m capsules are incorporated at up to 15 wt.% in PMMA and partial healing is 
observed both optically and by testing the protective capabilities of the healed films.  Full healing 
is obtained with larger capsules that supply more healing agent.  80 m heal both the optical and 
protective properties of PMMA above 6 wt.%.  A portion of the mechanical properties are also 
healed as observed visually.  When recracked after 3 days, the cracks propagate through the 
PMMA and can be seen after recracking suggesting that the DBP had diffused into the PMMA 
leaving a plasticized polymer in the healed region.   
 
6.2 Future Directions 
 This works opens several important directions that will contribute to the success of future 
self-healing system.  First, capsule stability is an important component for determining the 
lifetime of these self-healing materials but quantification of the stability is not trivial.  Thus, the 
various capsule parameters that may affect capsule stability and possible methods for quantifying 
capsule stability are discussed.  Second, self-healing polymer particles offer a wide range of 
possibilities for new self-healing chemistries where chemical reactions are eliminated, reducing 
the need to protect reactive components from deactivating species and high temperature.  Finally, 
several comments are included discussing how this research can help to advance research on 
other thermoplastic self-healing systems.   
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6.2.1 Capsule Stability 
 Several parameters are important for changing the properties of liquid-filled capsules and 
their thermal stability in air.  Shell material is the most important parameter and is typically 
chosen based on the solvent that will be encapsulated.[1-4]  Isocyanates, for example, cannot be 
encapsulated using a polyureaformaldehyde (PUF) shell due to reactions with the urea but can be 
encapsulated in a polyurethane shell.[2]  Previous work[3, 5] shows that the shell thickness has an 
important effect on the strength of the capsules and the time for diffusion of the inner contents 
across the shell wall.  Appropriate choice of the core material is also important.  The core liquid 
properties and its interactions with the shell wall are also important for stability as described in 
Table 6.1 and discussed in Chapter 2.  Finally, the capsule work-up is an extremely important 
component to recording consistent data.  While washing the capsules with ethanol affects capsule 
properties the most, many of the factors shown in Table 1 also cause slight changes in the capsule 
properties.   
 
Parameter What it affects 
Shell material Shell wall quality 
Shell thickness Time for core diffusion across shell wall 
Core interactivity with shell Shell wall quality 
Core volatility at RT Evaporation from shell wall 
Core molecule size Diffusion coefficient across shell wall 
Core boiling point Upper bound for use 
Core solubility in matrix resin Diffusion from shell wall during manufacture 
Core solubility in polymer matrix Diffusion from shell wall during normal operation 
Work-up Parameters: Solvent 
wash, wash time, dry time, sieve 
time 
Shell Quality 
 
Table 6.1. Capsule properties and their effects on the capsule stability. 
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While thermal stability in air has been the primary measure of capsule stability,[3, 6] it 
should only be used as an approximation of capsule stability since capsules will rarely see high 
temperatures during storage.  Instead, Table 6.2 highlights recommended tests to mimic more 
realistic conditions.  For many applications, storage stability is the most important capsule 
property since capsules only need to retain their contents until they are incorporated into a 
polymer.  As a result, capsules can be classified as: stable for short-term storage and stable for 
long-term storage.  The acceptable contents loss can be determined by the application and can be 
measured by TGA.  Once in a polymer, the shell wall becomes a thin diffusion barrier compared 
to the matrix itself requiring matrix stability tests.  Similar to the procedures outlined in Chapter 
2, the loss of contents from the matrix can be determined from XRay Computed Tomography 
(Xray CT) although light microscopy can be used to find the volume loss from capsules in a 
transparent polymer matrix.  The initial matrix stability is important for determining what 
capsules can be incorporated into a given polymer with minimal healing agent loss.  Accelerated 
matrix stability can be used to determine an approximate lifetime for a given self-healing 
polymer.  The final capsule environment that should be tested is solvent stability and is important 
for quantifying content loss during typical processing conditions and the solvent tested should 
include any resins, monomers, or organic solvents to which the capsules may be exposed.  Of 
these tests, short-term air stability, initial matrix stability and solvent stability are the most 
important parameters for academic research while specific applications will determine the exact 
requirements for the other tests.   
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Type of stability Environment Application 
Short-term air 
stability 
Capsules stored in air for 1 week.   
T = 25 C 
Self-healing polymer manufactured 
within 1 week of capsule synthesis 
Long-term air 
stability 
Capsules stored in air for 6 months 
T=25 C 
Long-term capsule storage required 
prior to manufacture 
Initial matrix 
stability 
Capsules stored in final polymer 
matrix for 1 week.  T= variable 
Benchmarking test 
Accelerated matrix 
stability 
Capsules stored in final polymer 
matrix for 2 months.  T>application 
temperature 
Benchmarking test 
Long-term matrix 
stability 
Capsules stored in final polymer 
matrix for expected life of polymer 
at application temperature 
Comparing capsule stability across 
various applications 
Solvent stability Solvent, temperature, and time are 
variable and should reflect the 
expected environment during self-
healing polymer manufacture 
Quantifying capsule contents loss 
during typical polymer processing 
conditions. 
 
Table 6.2. Potential Stability tests and their applications.   
 
6.2.2 Active Particle Stability 
 Many of the parameters that apply to capsules also apply to particles.  As a result of the 
solid nature of active particles, the key differences between these and capsules are: 
(1) Diffusion of species into the particle can lead to deactivation. 
(2) Quantification of active material cannot easily be done in real time. 
 
To date, active particle stability has focused primarily on Grubbs’ catalyst particles for 
use in epoxy matrices.  Loss of the catalyst results from diffusion of deactivating molecules into 
the particle.  Therefore, the environment has a key impact on how much healing agent is lost 
during storage and use.  Beyond the environment, the type of encapsulating material used plays 
the primary role in particle stability as discussed in Chapter 3.   
Many of the tests used to find the stability of liquid-filled capsules can be used to test 
active particles.  Because the quantity of healing agent in the particles cannot easily be measured 
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in real time, active particles are deemed to be those that have a minimum concentration of active 
material remaining after exposure to the different environments.  In Chapter 3, the catalyst 
activity is demonstrated by gel time in DCPD.  Particles that gelled DCPD in a certain time are 
deemed active.  This works well with catalyst where the concentration of catalyst in monomer can 
change without having a deleterious effect on the final healed polymer.  Other systems, however, 
may require more quantitative measurement techniques such as NMR or UV-vis.  One of the 
challenges to determining the quantity of Grubbs’ catalyst using these methods was the 
deactivation of the catalyst during the measurement process.  As a result, care must be taken to 
develop a procedure to separate the active particles from their environment without accidental 
loss of healing agent.   
 
6.2.3 New Applications with Thermoplastic Self-healing 
 One of the exciting aspects of the polymer particles developed in Chapter 3 is that they 
can be re-dissolved and deposited into the crack plane forming their own healed material without 
any chemical reactions taking place.  Therefore, temperature and matrix reactive groups do not 
play a role in deactivating the self-healing components.  Possible interactions between the healed 
polymer and polymer matrix include hydrogen bonding, Van der Waals bonding or mechanical 
interlocking.  For the system described in Chapter 4, polystyrene (PS) does provide some healing 
in epoxy but much of this is expected to be mechanical interlocking since PS particles larger than 
40 m do not show similar results and the primary difference between the two samples is the 
surface roughness of the crack plane.  Other polymers form better interactions with the crack 
plane through hydrogen bonding.  Proteins, for example, are known to adsorb strongly to a wide 
variety of surfaces.[7]   
A particularly intriguing thermoplastic system is one where a microfluidic network 
delivers a good solvent to the thermoplastic components.  The primary challenge with developing 
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this type of system is protecting the polymer matrix from dissolving into the solvent healing agent 
during normal operation.  CVD and ALD may be one possible solution for protecting the 
microfluidic channels.  In addition to the promise of multiple healing events, advantages to this 
system are similar to those discussed in Chapter 5: the healed material is the same as the initial 
polymer, allowing full healing, and index matching can result in optically clear self-healing 
polymers containing microfluidic networks.   
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